Omnicomm Systems (OMCM) 10-Q 13 Nov 13 2013 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Sep. 30, 2013	Nov. 13, 2013
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'OMNICOMM SYSTEMS INC	'
Document Type	'10-Q	'
Current Fiscal Year End Date	'--12-31	'
Entity Common Stock, Shares Outstanding	'	90,104,659
Amendment Flag	'false	'
Entity Central Index Key	'0001034592	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Well-known Seasoned Issuer	'No	'
Document Period End Date	30-Sep-13	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) (USD $)	Sep. 30, 2013	Dec. 31, 2012
ASSETS	'	'
Cash	$394,949	$873,315
Accounts receivable, net of allowance for doubtful accounts of $49,380 and $84,210, respectively	1,292,547	1,240,898
Prepaid expenses	137,974	131,942
Total current assets	1,825,470	2,246,155
Property and equipment, net	415,211	481,803
Prepaid stock compensation	187,917	0
Other assets	51,562	51,153
TOTAL ASSETS	2,480,160	2,779,111
CURRENT LIABILITIES	'	'
Accounts payable and accrued expenses	2,006,180	2,124,365
Notes payable, current portion	17,500	0
Deferred revenue, current portion	3,414,966	3,732,240
Line of credit	800,000	0
Convertible notes payable, related parties, current portion, net of discount	160,000	160,000
Convertible notes payable, current portion, net of discount	275,000	75,000
Patent settlement liability, current portion	962,500	962,500
Total current liabilities	19,135,880	15,629,026
LONG TERM LIABILITIES	'	'
Notes payable, long term, net of current portion	634,487	651,987
Notes payable, related parties, long term, net of current portion, net of discount of $599,916 and $656,524, respectively	4,415,963	3,830,355
Deferred revenue, long term, net of current portion	1,220,998	987,328
Convertible notes payable, related parties, net of current portion	8,965,000	8,965,000
Convertible notes payable, net of current portion	265,000	465,000
Patent settlement liability, long term, net of current portion	1,031,188	1,223,715
TOTAL LIABILITIES	35,668,516	31,752,411
COMMITMENTS AND CONTINGENCIES (See Note 11)	'	'
SHAREHOLDERS' (DEFICIT)	'	'
Preferred stock	0	0
Common stock - 250,000,000 shares authorized, 87,834,659 and 86,598,659 issued and outstanding, respectively, at $0.001 par value	87,835	86,599
Additional paid in capital - preferred	4,717,804	4,717,804
Additional paid in capital - common	36,926,907	36,645,589
Accumulated other comprehensive (loss)	-99,577	-69,092
Accumulated deficit	-74,825,700	-70,358,575
TOTAL SHAREHOLDERS' (DEFICIT)	-33,188,356	-28,973,300
TOTAL LIABILITIES AND SHAREHOLDERS' (DEFICIT)	2,480,160	2,779,111
Conversion Feature Liability, Related Parties [Member]	'	'
CURRENT LIABILITIES	'	'
Derivative liabilities, current	3,882,966	2,240,782
Conversion Feature Liability [Member]	'	'
CURRENT LIABILITIES	'	'
Derivative liabilities, current	141,592	46,541
Warrant Liability, Related Parties [Member]	'	'
CURRENT LIABILITIES	'	'
Derivative liabilities, current	7,336,989	6,095,153
Warrant Liability [Member]	'	'
CURRENT LIABILITIES	'	'
Derivative liabilities, current	138,187	192,445
Series B Preferred Stock [Member]	'	'
SHAREHOLDERS' (DEFICIT)	'	'
Preferred stock	0	0
Series C Preferred Stock [Member]	'	'
SHAREHOLDERS' (DEFICIT)	'	'
Preferred stock	0	0
Series A Preferred Stock [Member]	'	'
SHAREHOLDERS' (DEFICIT)	'	'
Preferred stock	4,125	4,125
Series D Preferred Stock [Member]	'	'
SHAREHOLDERS' (DEFICIT)	'	'
Preferred stock	$250	$250

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Allowance for doubtful accounts (in Dollars)	$49,380	$84,210
Preferred stock, par value (in Dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares undesignated (in Dollars)	3,772,500	3,772,500
Shares Outstanding	4,125,224	'
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	87,834,659	86,598,659
Common stock, shares outstanding	87,834,659	86,598,659
Common stock, par value (in Dollars per share)	$0.00	$0.00
Series B Preferred Stock [Member]	'	'
Preferred stock, par value (in Dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	230,000	230,000
Shares Issued	0	0
Shares Outstanding	0	0
Liquidation Preference (in Dollars)	0	0
Series C Preferred Stock [Member]	'	'
Preferred stock, par value (in Dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	747,500	747,500
Shares Issued	0	0
Shares Outstanding	0	0
Liquidation Preference (in Dollars)	0	0
Series A Preferred Stock [Member]	'	'
Preferred stock, par value (in Dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	5,000,000	5,000,000
Shares Issued	4,125,224	4,125,224
Shares Outstanding	4,125,224	4,125,224
Liquidation Preference (in Dollars)	4,125,224	4,125,224
Series D Preferred Stock [Member]	'	'
Preferred stock, par value (in Dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	250,000	250,000
Shares Issued	250,000	250,000
Shares Outstanding	250,000	250,000
Notes Payable, Related Parties, Long Term [Member]	'	'
Notes payable, related parties, long term, net of current portion, discount (in Dollars)	$599,916	$656,524

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenues	$3,449,661	$3,894,656	$10,543,197	$11,317,590
Reimbursable revenues	27,960	163,664	412,947	579,898
Total revenues	3,477,621	4,058,320	10,956,144	11,897,488
Cost of goods sold	648,369	690,763	1,942,126	2,020,507
Gross margin	2,765,142	3,317,268	8,716,690	9,479,164
Operating expenses	'	'	'	'
Salaries, benefits and related taxes	2,130,385	2,086,203	6,496,528	6,374,375
Rent and occupancy expenses	199,492	226,979	665,932	649,424
Consulting services	14,496	77,060	117,410	144,496
Legal and professional fees	53,312	39,512	205,767	236,967
Travel	100,860	86,240	326,578	292,323
Telephone and internet	38,618	38,317	131,476	111,921
Selling, general and administrative	197,765	232,371	634,481	698,512
Bad debt expense	8,191	42,619	-4,830	126,763
Depreciation expense	54,894	75,912	174,436	308,666
Amortization expense	0	0	0	232,117
Total operating expenses	2,798,013	2,905,213	8,747,778	9,175,564
Operating income/(loss)	-32,871	412,055	-31,088	303,600
Other income/(expense)	'	'	'	'
Interest expense	-37,760	-28,649	-107,952	-89,537
Interest expense, related parties	-588,425	-527,442	-1,750,327	-1,573,444
Interest income	3	17	9	225
Change in derivative liabilities	2,418,612	-4,215,476	-2,524,671	-4,804,260
Loss on sale of fixed assets	0	0	0	-22,106
Transaction gain/(loss)	3,780	973	-4,497	6
Income/(loss) before income taxes	1,763,339	-4,358,522	-4,418,526	-6,185,516
Income taxes	-30,869	-54,699	-48,599	-54,699
Net income/(loss)	1,732,470	-4,413,221	-4,467,125	-6,240,215
Preferred stock dividends	'	'	'	'
Preferred stock dividends	-51,989	-51,989	-154,272	-177,528
Net income/(loss) attributable to common stockholders	1,680,481	-4,465,210	-4,621,397	-6,417,743
Basic and diluted (in Dollars per share)	$0.02	($0.05)	($0.05)	($0.07)
Basic and diluted (in Shares)	87,867,268	86,526,332	87,515,641	86,496,550
Reimbursable expenses-cost of goods sold	64,110	50,289	297,328	397,817
Cost of Goods Sold, Including Reimbursable Expenses [Member]	'	'	'	'
Cost of goods sold	712,479	741,052	2,239,454	2,418,324
Preferred Class A [Member]	'	'	'	'
Preferred stock dividends	'	'	'	'
Preferred stock dividends	($51,989)	($51,989)	($154,272)	($177,528)

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income/ (Loss) (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Net income/(loss) attributable to common stockholders	$1,680,481	($4,465,210)	($4,621,397)	($6,417,743)
Other comprehensive income/(loss)	'	'	'	'
Change in foreign currency translation adjustment	-3,006	-3,398	-30,485	-10,586
Other comprehensive income/(loss)	-3,006	-3,398	-30,485	-10,586
Comprehensive income/(loss)	$1,677,475	($4,468,608)	($4,651,882)	($6,428,329)

Condensed_Consolidated_Stateme2

Condensed Consolidated Statement of Shareholders' (Deficit) (Unaudited) (USD $)	Series A Preferred Stock [Member]	Series B Preferred Stock [Member]	Series C Preferred Stock [Member]	Series D Preferred Stock [Member]	Additional Paid In Capital, Preferred [Member]	Common Stock [Member]	Additional Paid In Capital, Common [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total
Balances at December 31, 2011 at Dec. 31, 2011	$4,125	$0	$0	$250	$4,717,804	$86,482	$36,572,099	($62,525,605)	($53,714)	($21,198,559)
Balances at December 31, 2011 (in Shares) at Dec. 31, 2011	4,125,224	0	0	250,000	'	86,481,495	'	'	'	'
Employee stock option expense	'	'	'	'	'	'	65,744	'	'	65,744
Foreign currency translation adjustment	'	'	'	'	'	'	'	'	-15,378	-15,378
Issuance of common stock in lieu of accrued interest	'	'	'	'	'	42	7,821	'	'	7,863
Issuance of common stock in lieu of accrued interest (in Shares)	'	'	'	'	'	42,164	'	'	'	'
Employee stock option exercise	'	'	'	'	'	75	-75	'	'	0
Employee stock option exercise (in Shares)	'	'	'	'	'	75,000	'	'	'	-265,000
Net loss for the period	0	0	0	0	0	0	0	-7,832,970	0	-7,832,970
Ending Balance at Dec. 31, 2012	4,125	0	0	250	4,717,804	86,599	36,645,589	-70,358,575	-69,092	-28,973,300
Ending Balance (in Shares) at Dec. 31, 2012	4,125,224	0	0	250,000	'	86,598,659	'	'	'	'
Employee stock option expense	'	'	'	'	'	'	60,054	'	'	60,054
Foreign currency translation adjustment	'	'	'	'	'	'	'	'	-30,485	-30,485
Restricted stock issuance	'	'	'	'	'	1,225	221,275	'	'	222,500
Restricted stock issuance (in Shares)	'	'	'	'	'	1,225,000	'	'	'	'
Employee stock option exercise	'	'	'	'	'	11	-11	'	'	0
Employee stock option exercise (in Shares)	'	'	'	'	'	11,000	'	'	'	-100,000
Net loss for the period	0	0	0	0	0	0	0	-4,467,125	0	-4,467,125
Ending Balance at Sep. 30, 2013	$4,125	$0	$0	$250	$4,717,804	$87,835	$36,926,907	($74,825,700)	($99,577)	($33,188,356)
Ending Balance (in Shares) at Sep. 30, 2013	4,125,224	0	0	250,000	'	87,834,659	'	'	'	'

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended		12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES	'	'	'
Net loss	($4,467,125)	($6,240,215)	($7,832,970)
Adjustment to reconcile net loss to net cash (used in) operating activities	'	'	'
Change in derivative liabilities	2,524,671	4,804,260	'
Interest expense from derivative instruments	456,750	356,715	'
Loss from sale of fixed assets, net	0	14,606	'
Employee stock option expense	60,054	47,211	65,744
Amortization of prepaid compensation	34,583	0	'
Provision for doubtful accounts	-4,830	126,763	-58,234
Depreciation and amortization	174,436	540,783	'
Changes in operating assets and liabilities	'	'	'
Accounts receivable	-46,819	-134,757	'
Prepaid expenses	-6,032	-10,029	'
Other assets	-409	-17,004	'
Accounts payable and accrued expenses	410,815	452,712	'
Patent settlement liability	-192,527	-133,557	'
Deferred revenue	-83,604	-103,145	'
Net cash (used in) operating activities	-1,140,037	-295,657	'
CASH FLOWS FROM INVESTING ACTIVITIES	'	'	'
Proceeds from sale of property and equipment	0	50,000	'
Purchase of property and equipment	-107,844	-108,698	'
Net cash (used in) investing activities	-107,844	-58,698	'
CASH FLOWS FROM FINANCING ACTIVITIES	'	'	'
Repayments of notes payable	0	-131,800	'
Proceeds from revolving line of credit	800,000	0	'
Net cash provided by/(used in) financing activities	800,000	-131,800	'
Effect of exchange rate changes on cash and cash equivalents	-30,485	-10,586	'
Net decrease in cash and cash equivalent	-478,366	-496,741	'
Cash and cash equivalents at beginning of period	873,315	1,302,287	1,302,287
Cash and cash equivalents at end of period	394,949	805,546	873,315
Supplemental disclosures of cash flow information:	'	'	'
Income taxes	48,599	54,699	'
Interest	725,546	1,242,079	'
Non-cash transactions	'	'	'
Notes payable issued in exchange for existing notes payable	2,866,879	0	'
Promissory Notes Issued for Accrued Interest [Member]	'	'	'
Non-cash transactions	'	'	'
Promissory notes issued for accrued interest	$529,000	$0	'

Note_1_Organization_and_Nature

Note 1 - Organization and Nature of Operations	9 Months Ended
	Sep. 30, 2013
Disclosure Text Block [Abstract]	'
Nature of Operations [Text Block]	'
	NOTE 1:                ORGANIZATION AND NATURE OF OPERATIONS
	OmniComm Systems, Inc. (“OmniComm” or the “Company”) is a healthcare technology company that provides Web-based electronic data capture (“EDC”) solutions and related value-added services to pharmaceutical and biotech companies, clinical research organizations, and other clinical trial sponsors principally located in the United States and Europe. Our proprietary EDC software applications; TrialMaster®, TrialOne®, and eClinical Suite, allow clinical trial sponsors and investigative sites to securely collect, validate, transmit, and analyze clinical trial data.
	Our ability to compete within the EDC industry is predicated on our ability to continue enhancing and broadening the scope of solutions offered through our EDC software and services. Our research and development (sometimes referred to as “R & D”) efforts are focused on developing new and complementary software solutions, as well as enhancing our existing software solutions through the addition of increased functionality. During the nine month periods ended September 30, 2013 and September 30, 2012 we spent approximately $1,718,079 and $1,867,778, respectively, on research and development activities, which is primarily comprised of salaries to our developers and other R & D personnel and related costs associated with the development of our software products.

Note_2_Summary_of_Significant_

Note 2 - Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

'

Significant Accounting Policies [Text Block]

'

NOTE 2:                SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION

The Company’s accounts include those of all its wholly-owned subsidiaries, which are more fully described in the Company’s 2012 Annual Report filed on Form 10-K with the Securities and Exchange Commission, and have been prepared in conformity with (i) accounting principles generally accepted in the United States of America; and (ii) the rules and regulations of the United States Securities and Exchange Commission. All significant intercompany accounts and transactions between the Company and its subsidiaries have been eliminated in consolidation.

UNAUDITED FINANCIAL STATEMENTS

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, pursuant to the rules and regulations of the Securities and Exchange Commission. Pursuant to such rules and regulations, certain financial information and footnote disclosures normally included in the consolidated financial statements have been condensed or omitted. The results for the periods indicated are unaudited, but reflect all adjustments (consisting only of normally recurring adjustments) which management considers necessary for a fair presentation of operating results.

The operating results for the three and nine month periods ended September 30, 2013 are not necessarily indicative of the results that may be expected for the year-ended December 31, 2013. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year-ended December 31, 2012.

ESTIMATES IN FINANCIAL STATEMENTS

The preparation of the unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Significant estimates incorporated in our financial statements include the recorded allowance for doubtful accounts, the estimate of the appropriate amortization period of our intangible assets, the evaluation of whether our intangible assets have suffered any impairment, the allocation of revenues under multiple-element customer contracts, royalty-based patent liabilities, the value of derivatives associated with debt issued by the Company and the valuation of any corresponding discount to the issuance of our debt. Actual results may differ from those estimates.

Reclassifications

Certain reclassifications have been made in the 2012 financial statements to conform to the 2013 presentation. These reclassifications did not have any effect on our net loss or shareholders’ deficit.

foreign currency translation

The financial statements of the Company’s foreign subsidiaries are translated in accordance with ASC 830-30, Foreign Currency Matters—Translation of Financial Statements. The reporting currency for the Company is the U.S. dollar. The functional currency of the Company’s subsidiaries, OmniComm Europe GmbH in Germany and OmniComm Spain S.L. in Spain is the Euro. The functional currency of the Company’s subsidiary OmniComm Ltd., in the United Kingdom, is the British Pound Sterling. Accordingly, the assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars using the exchange rate in effect at each balance sheet date. Revenue and expense accounts of the Company’s foreign subsidiaries are translated using an average rate of exchange during the period. Foreign currency translation adjustments are accumulated as a component of other comprehensive income/(loss) as a separate component of stockholders’ equity. Gains and losses arising from transactions denominated in foreign currencies are primarily related to intercompany accounts that have been determined to be temporary in nature and accordingly, are recorded directly to the statement of operations. We record translation gains and losses in accumulated other comprehensive income as a component of stockholders’ equity. We recorded translation losses of $30,485 and $10,586 for the nine month periods ended September 30, 2013 and September 30, 2012 respectively.

REVENUE RECOGNITION POLICY

The Company derives revenues from software licenses and services of its EDC products and services which can be purchased on a stand-alone basis. License revenues are derived principally from the sale of term licenses for the following software products offered by the Company: TrialMaster, TrialOne and eClinical Suite (the “EDC Software”). Service revenues are derived principally from the Company's delivery of the hosted solutions of its TrialMaster and eClinical Suite software products, and consulting services and customer support, including training, for all of the Company's products.

The Company recognizes revenues when all of the following conditions are satisfied: (1) there is persuasive evidence of an arrangement; (2) the product or service has been provided to the customer; (3) the collection of fees is probable; and (4) the amount of fees to be paid by the customer is fixed or determinable.

The Company operates in one reportable segment which is the delivery of EDC Software and services to clinical trial sponsors. The Company segregates its revenues based on the activity cycle used to generate its revenues. Accordingly, revenues are currently generated through four main activities, including hosted applications, licensing, professional services and maintenance-related services.

Hosted Application Revenues

The Company offers its TrialMaster and eClinical Suite software products as hosted application solutions delivered through a standard Web-browser, with customer support and training services. The Company's TrialOne solution is presently available only on a licensed basis. To date, hosted applications revenues have been primarily related to TrialMaster.

Revenues resulting from TrialMaster and eClinical Suite application hosting services consist of three components of services for each clinical trial. The first component is comprised of application set up, including design of electronic case report forms and edit checks, installation and server configuration of the system. The second component involves application hosting and related support services as well as billable change orders which consist of amounts billed to customers for functionality changes made. The third stage involves services required to close out, or lock, the database for the clinical trial.

Fees charged and costs incurred for the trial system design, set up and implementation are amortized and recognized ratably over the estimated hosting period. Work performed outside the original scope of work is contracted for separately as an additional fee and is generally recognized ratably over the remaining term of the hosting period. Fees for the first and third stages of the service are billed based upon milestones. Revenues earned upon completion of a contractual milestone are deferred and recognized over the estimated remaining hosting period. Fees for application hosting and related services in the second stage are generally billed quarterly in advance. Revenues resulting from hosting services for the eClinical Suite products consist of installation and server configuration, application hosting and related support services. Services for this offering are generally charged as a fixed fee payable on a quarterly or annual basis. Revenues are recognized ratably over the period of the service.

Licensing Revenues

The Company's software license revenues are earned from the sale of off-the-shelf software. From time-to-time a client might require significant modification or customization subsequent to delivery to the customer. The Company generally enters into software term licenses for its EDC Software products with its customers for three to five year periods, although customers have entered into both longer and shorter term license agreements. These arrangements typically include multiple elements: software license, consulting services and customer support. The Company bills its customers in accordance with the terms of the underlying contract. Generally, the Company bills license fees in advance for each billing cycle of the license term, which typically is either on a quarterly or annual basis. Payment terms are generally net 30 days.

In the past the Company has sold perpetual licenses for EDC Software products in certain situations to existing customers with the option to purchase customer support, and may, in the future, do so for new customers based on customer requirements or market conditions. The Company has established vendor specific objective evidence of fair value for the customer support. Accordingly, license revenues are recognized upon delivery of the software and when all other revenue recognition criteria are met. Customer support revenues are recognized ratably over the term of the underlying support arrangement. The Company generates customer support and maintenance revenues from its perpetual license customer base.

Professional Services

The Company may also enter into arrangements to provide consulting services separate from a license arrangement. In these situations, revenue is recognized on a time-and-materials basis. Professional services can be deemed to be as essential to the functionality of the software at inception and typically are for initial trial configuration, implementation planning, loading of software, building simple interfaces, running test data and documentation of procedures. Subsequent additions or extensions to license terms do not generally include additional professional services.

Pass-through Revenue and Expense

The Company accounts for pass-through revenue and expense in accordance with ASC 605-45, Principal Agent Considerations. In accordance with ASC 605-45, Principal Agent Consideration, these amounts are recorded as revenue in the statement of operations with a corresponding expense recorded in cost of goods sold. Pass-through revenues and expenses include amounts associated with third-party services provided to our customers by our service and product partners. These third-party services are primarily comprised of Interactive Voice and Web Response software services (IVR and IWR), travel and shipping that are incurred on our clients’ behalf.

Maintenance Revenues

Maintenance includes telephone-based help desk support and software maintenance. The Company generally bundles customer support with the software license for the entire term of the arrangement. As a result, the Company generally recognizes revenues for both maintenance and software licenses ratably over the term of the software license and support arrangement. The Company allocates the revenues recognized for these arrangements to the different elements based on management's estimate of the relative fair value of each element. The Company generally invoices each of the elements based on separately quoted amounts and thus has a fairly accurate estimate of the relative fair values of each of the invoiced revenue elements.

The fees associated with each business activity for the periods ended September 30, 2013 and September 30, 2012, respectively are:

For the nine months ended

Revenue activity

30-Sep-13

30-Sep-12

Set-up fees

$

2,584,285

$

4,085,437

Change orders

344,400

202,498

Maintenance

3,495,908

3,928,079

Software licenses

2,333,016

2,525,933

Professional services

1,625,600

638,302

Hosting

572,935

517,239

Total

$

10,956,144

$

11,897,488

For the three months ended

Revenue activity

30-Sep-13

30-Sep-12

Set-up fees

$

988,990

$

1,458,304

Change orders

119,870

48,417

Maintenance

1,186,023

1,307,547

Software licenses

430,323

847,297

Professional services

552,719

213,187

Hosting

199,696

183,568

Total

$

3,477,621

$

4,058,320

COST OF REVENUES

Cost of revenues primarily consists of costs related to hosting, maintaining and supporting the Company’s application suite and delivering professional services and support. These costs include salaries, benefits, bonuses and stock-based compensation for the Company’s professional services staff. Cost of revenues also includes outside service provider costs. Cost of revenues is expensed as incurred.

CASH AND CASH EQUIVALENTS

Cash equivalents consist of highly liquid, short-term investments with maturities of 90 days or less. The carrying amount reported in the accompanying consolidated balance sheets approximates fair value.

ACCOUNTS RECEIVABLE

Accounts receivable are judged as to collectability by management and an allowance for bad debts is established as necessary. The allowance is based on an evaluation of the collectability of accounts receivable and prior bad debt experience. The Company had recorded an allowance for uncollectible accounts receivable of $49,380 as of September 30, 2013 and $84,210 as of December 31, 2012, respectively.

The following table summarizes activity in the Company's allowance for doubtful accounts for the periods presented.

30-Sep-13

31-Dec-12

Beginning of period

$

84,210

$

142,444

Bad debt expense

(4,830

)

(58,234

)

Write-offs

(30,000

)

-0-

End of period

$

49,380

$

84,210

Concentration of Credit Risk

Cash and cash equivalents and restricted cash are deposited with major financial institutions and, at times, such balances with any one financial institution may be in excess of FDIC-insured limits. As of September 30, 2013, $129,390 was deposited in excess of FDIC-insured limits. Management believes the risk in these situations to be minimal.

Except as follows, the Company has no significant off-balance-sheet risk or credit risk concentrations. Financial instruments that subject the Company to potential credit risks are principally cash equivalents and accounts receivable. Concentrated credit risk with respect to accounts receivable is limited to creditworthy customers. The Company's customers are principally located in the United States and Europe. The Company is directly affected by the overall financial condition of the pharmaceutical, biotechnology and medical device industries and management believes that credit risk exists and that any credit risk the Company faces has been adequately reserved for as of September 30, 2013. The Company maintains an allowance for doubtful accounts based on accounts past due according to contractual terms and historical collection experience. Actual losses when incurred are charged to the allowance. The Company's losses related to collection of accounts receivable have consistently been within management's expectations. As of September 30, 2013, the Company believes no additional credit risk exists beyond the amounts provided for in our allowance for uncollectible accounts. The Company evaluates its allowance for uncollectable accounts on a monthly basis based on a specific review of receivable aging and the period that any receivables are beyond the standard payment terms. The Company does not require collateral from its customers in order to mitigate credit risk.

One customer accounted for 11% of our revenues during the nine month period ended September 30, 2013 or approximately $1,221,000 and another customer accounted for 9% or approximately $959,000. One customer accounted for 21% of our revenues during the nine month period ended September 30, 2012 or approximately $2,442,000 and another customer accounted for 17% or approximately $2,043,000. The following table summarizes the number of customers who individually comprise greater than 10% of total revenue and/or total accounts receivable and their aggregate percentage of the Company's total revenue and gross accounts receivable for the periods presented.

Revenues

Accounts receivable

For the period ended

Number of

Percentage of

Number of

Percentage of

customers

total revenues

customers

accounts receivable

30-Sep-13

1

11%

2

29%

31-Dec-12

2

35%

3

54%

30-Sep-12

2

38%

1

13%

The table below provides revenues from European customers for the nine month periods ended September 30, 2013 and September 30, 2012, respectively.

European revenues

For the nine months ended

30-Sep-13

30-Sep-12

European revenues

% of Total revenues

European revenues

% of Total revenues

$

1,214,121

11%

$

1,157,462

10%

The Company serves all of its hosting customers from third-party web hosting facilities located in the United States. The Company does not control the operation of these facilities, and they are vulnerable to damage or interruption. The Company maintains redundant systems that can be used to provide service in the event the third-party web hosting facilities become unavailable, although in such circumstances, the Company's service may be interrupted during the transition.

PROPERTY AND EQUIPMENT

Property and equipment are recorded at cost. Additions and betterments are capitalized; maintenance and repairs are expensed as incurred. Depreciation is calculated using the straight-line method over the asset’s estimated useful life, which is 5 years for leasehold improvements, computers, equipment and furniture and 3 years for software. Gains or losses on disposal are charged to operations.

ASSET IMPAIRMENT

Acquisitions and Intangible Assets

We account for acquisitions in accordance with ASC 805, Business Combinations (“ASC 805”) and ASC 350, Intangibles- Goodwill and Other (“ASC 350”). The acquisition method of accounting requires that assets acquired and liabilities assumed be recorded at their fair values on the date of a business acquisition. Our consolidated financial statements and results of operations reflect an acquired business from the completion date of an acquisition.

The judgments that we make in determining the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact net income in periods following an asset acquisition. We generally use either the income, cost or market approach to aid in our conclusions of such fair values and asset lives. The income approach presumes that the value of an asset can be estimated by the net economic benefit to be received over the life of the asset, discounted to present value. The cost approach presumes that an investor would pay no more for an asset than its replacement or reproduction cost. The market approach estimates value based on what other participants in the market have paid for reasonably similar assets. Although each valuation approach is considered in valuing the assets acquired, the approach ultimately selected is based on the characteristics of the asset and the availability of information.

Long-lived Assets

We review long-lived assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment has occurred typically requires various estimates and assumptions, including determining which cash flows are directly related to the potentially impaired asset, the useful life over which cash flows will occur, their amount and the asset’s residual value, if any. In turn, measurement of an impairment loss requires a determination of fair value, which is based on the best information available. We use quoted market prices when available and independent appraisals and management estimates of future operating cash flows, as appropriate, to determine fair value.

FAIR VALUE MEASUREMENT

OmniComm’s capital structure includes the use of warrants and convertible debt features that are classified as derivative financial instruments. Derivative financial instruments are recognized as either assets or liabilities and are measured at fair value under ASC 815 Derivatives and Hedging. ASC 815 requires that changes in the fair value of derivative financial instruments with no hedging designation be recognized as gains/(losses) in the earnings statement. The fair value measurement is determined in accordance with ASC 820 Fair Value Measurements and Disclosures.

DEFERRED REVENUE

Deferred revenue represents cash advances and amounts in accounts receivable as of the balance sheet date received in excess of revenue earned on on-going contracts. Payment terms vary with each contract but may include an initial payment at the time the contract is executed, with future payments dependent upon the completion of certain contract phases or targeted milestones. In the event of contract cancellation, the Company is generally entitled to payment for all work performed through the point of cancellation. As of September 30, 2013, the Company had $4,635,964 in deferred revenues relating to contracts for services to be performed over periods ranging from one month to five years. The Company had $3,414,966 in deferred revenues that are expected to be recognized in the next twelve fiscal months.

ADVERTISING

Advertising costs are expensed as incurred. Advertising costs were $175,095 and $191,894 for the nine month periods ended September 30, 2013 and September 30, 2012, respectively and are included under selling, general and administrative expenses on our consolidated financial statements.

RESEARCH AND DEVELOPMENT EXPENSES

Software development costs are included in research and development and are expensed as incurred. ASC 985.20, Software Industry Costs of Software to Be Sold, Leased or Marketed, requires the capitalization of certain development costs of software to be sold once technological feasibility is established, which the Company defines as completion to the point of marketability. The capitalized cost is then amortized on a straight-line basis over the estimated product life. To date, the period between achieving technological feasibility and the general availability of such software has been short and software development costs qualifying for capitalization have been immaterial. Accordingly, the Company has not capitalized any software development costs under ASC 985.20. During the nine month periods ended September 30, 2013 and September 30, 2012 we spent approximately $1,718,079 and $1,867,778 respectively, on research and development activities, which include costs associated with the development of our software products and services for our clients’ projects and which are primarily comprised of salaries and related expenses for our software developers and consulting fees paid to third-party consultants. Research and development costs are primarily included under Salaries, benefits and related taxes in our Statement of Operations.

EMPLOYEE EQUITY INCENTIVE PLANS

The OmniComm Systems, Inc. 2009 Equity Incentive Plan (the “2009 Plan”) was approved at our Annual Meeting of Shareholders on July 10, 2009. The 2009 Plan provides for the issuance of up to 7,500,000 shares to employees, directors and key consultants in accordance with the terms of the 2009 Plan documents. The predecessor plan, the OmniComm Systems, Inc., 1998 Stock Incentive Plan (the “1998 Plan”) expired on December 31, 2008. The 1998 Plan provided for the issuance of up to 12,500,000 shares in accordance with the terms of the 1998 Plan document. Each plan is more fully described in “Note 14, Employee Equity Incentive Plans.” The Company accounts for its employee equity incentive plans under ASC 718, Compensation – Stock Compensation which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions.

ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the Company’s consolidated statements of operations. The Company currently uses the Black Scholes option pricing model to determine grant date fair value.

EARNINGS PER SHARE

The Company accounts for Earnings per Share using ASC 260 – Earnings per Share. Unlike diluted earnings per share, basic earnings per share excludes any dilutive effects of options, warrants, and convertible securities.

INCOME TAXES

The Company accounts for income taxes in accordance with ASC 740, Income Taxes. ASC 740 has as its basic objective the recognition of current and deferred income tax assets and liabilities based upon all events that have been recognized in the financial statements as measured by the provisions of the enacted tax laws.

Valuation allowances are established when necessary to reduce deferred tax assets to the estimated amount to be realized. Income tax expense represents the tax payable for the current period and the change during the period in the deferred tax assets and liabilities.

IMPACT OF NEW ACCOUNTING STANDARDS

During the first nine months of 2013, we adopted the following new accounting pronouncements:

In July 2012, FASB issued Accounting Standards Update 2012-02, Balance Sheet- Intangibles- Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment (“ASU 2012-02”). ASU 2012-002 is an Amendment to FASB Accounting Standards Update 2011-08. The objective of the amendments in this Update is to reduce the cost and complexity of performing an impairment test for indefinite-lived intangible assets by simplifying how an entity tests those assets for impairment and to improve consistency in impairment testing guidance among long-lived asset categories. The amendments permit an entity first to assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test in accordance with Subtopic 350-30, Intangibles—Goodwill and Other—General Intangibles Other than Goodwill. The more-likely-than-not threshold is defined as having a likelihood of more than 50 percent. The amendments are effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. The Company adopted ASU 2012-02 on January 1, 2013, and the adoption did not have a material impact on its consolidated financial position or results of operations.

In February 2013, FASB issued Accounting Standards Update 2013-02, Comprehensive Income (Topic 220) (“ASU 2013-02”). ASU 2013-002 provides guidance on the presentation of amounts reclassified out of accumulated other comprehensive income. This update requires an entity to provide information about the amounts reclassified from accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in the notes, significant amounts reclassified from accumulated other comprehensive income by the net income line item. The Company adopted ASU 2013-02 as of January 1, 2013, and the adoption did not have a material impact on its consolidated financial position or results of operations.

Accounting standards-setting organizations frequently issue new or revised accounting rules. We regularly review all new pronouncements to determine their impact, if any, on our financial statements.

Note_3_Going_Concern

Note 3 - Going Concern	9 Months Ended
	Sep. 30, 2013
Going Concern Note [Abstract]	'
Going Concern Note	'
	NOTE 3:                GOING CONCERN
	We have experienced net losses and negative cash flows from operations and have utilized debt and equity financings to help provide for our working capital, capital expenditure and R&D needs. We will continue to require substantial funds to continue our research and development activities and to market, sell and commercialize our technology. We may need to raise substantial additional capital to fund our future operations. Our capital requirements will depend on many factors, including the following: problems, delays, expenses and complications frequently encountered by companies developing and commercializing new technologies; the progress of our research and development activities; the rate of technological advances; determinations as to the commercial potential of our technology under development; the status of competitive technology; the establishment of collaborative relationships; the success of our sales and marketing programs; and other changes in economic, regulatory or competitive conditions in our planned business.
	Estimates about the adequacy of funding for our activities are based upon certain assumptions, including assumptions that the research and development programs relating to our technology can be conducted at projected costs and that progress towards the commercialization of our technology will be timely and successful. There can be no assurance that changes in our research and development plans, acquisitions or other events will not result in accelerated or unexpected expenditures.
	To satisfy our capital requirements, we may seek additional financing through debt and equity financings. There can be no assurance that any such funding will be available to us on favorable terms or at all. If adequate funds are not available when needed, we may be required to delay, scale back or eliminate some or all of our research and product development and marketing programs. If we are successful in obtaining additional financings, the terms of such financings may have the effect of diluting or adversely affecting the holdings or the rights of the holders of our common and preferred stock or result in increased interest expense in future periods.
	The ability of the Company to continue in existence is dependent on its having sufficient financial resources to bring products and services to market for marketplace acceptance. As a result of our historical operating losses, negative cash flows and accumulated deficits for the period ending September 30, 2013 there is substantial doubt about the Company’s ability to continue as a going concern.
	The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Note_4_Earnings_Loss_Per_Share

Note 4 - Earnings (Loss) Per Share	9 Months Ended
	Sep. 30, 2013
Earnings Per Share [Abstract]	'
Earnings Per Share [Text Block]	'
	NOTE 4.                EARNINGS (LOSS) PER SHARE
	Basic earnings (loss) per share were calculated using the weighted average number of shares outstanding of 87,515,641 and 86,496,550 for the nine month periods ended September 30, 2013 and September 30, 2012, respectively.
	Basic earnings (loss) per share were calculated using the weighted average number of shares outstanding of 87,867,268 and 86,526,332 for the three month periods ended September 30, 2013 and September 30, 2012, respectively.
	Antidilutive shares aggregating 79,502,620 and 82,521,509 have been omitted from the calculation of dilutive earnings (loss) per share for the nine month periods ended September 30, 2013 and September 30, 2012, respectively, as the shares were antidilutive. Provided below is the reconciliation between numerators and denominators of the basic and diluted earnings per shares: There were no differences between basic and diluted earnings per share for the nine month periods ended September 30. The table below provides a reconciliation of anti-dilutive securities outstanding as of September 30, 2013 and September 30, 2012, respectively.
	Anti-dilutive security	30-Sep-13			30-Sep-12
	Preferred stock		2,750,149			2,750,149
	Employee stock options		6,175,000			10,502,500
	Warrants		44,728,873			44,089,580
	Convertible notes		24,620,000			24,620,000
	Shares issuable for accrued interest		1,228,598			559,280
	Total		79,502,620			82,521,509
	The employee stock options are exercisable at prices ranging from $0.045 to $0.69 per share. The exercise price on the stock warrants range from $0.25 to $0.60 per share. Shares issuable upon conversion of Convertible Debentures have conversion prices ranging from $0.25 to $0.50 per share.
	The Company’s convertible debt and convertible preferred stock have an anti-dilutive effect on net income (loss) per share and were not included in the computation of diluted earnings per share.
	For the nine months ended
		30-Sep-13								30-Sep-12
		Income (loss)			Shares		Per-share			Income (loss)			Shares		Per-share
		numerator			denominator		amount			numerator			denominator		amount
	Basic EPS	$	(4,621,397	)		87,515,641	$	(0.05	)	$	(6,417,743	)		86,496,550	$	(0.07	)
	Effect of dilutive securities
	None		-0-			-0-		-0-			-0-			-0-		-0-
	Diluted EPS	$	(4,621,397	)		87,515,641	$	(0.05	)	$	(6,417,743	)		86,496,550	$	(0.07	)
	For the three months ended
		30-Sep-13								30-Sep-12
		Income (loss)			Shares		Per-share			Income (loss)			Shares		Per-share
		numerator			denominator		amount			numerator			denominator		amount
	Basic EPS	$	1,680,481			87,867,268	$	0.02		$	(4,465,210	)		86,526,332	$	(0.05	)
	Effect of dilutive securities
	None		-0-			-0-		-0-			-0-			-0-		-0-
	Diluted EPS	$	1,680,481			87,867,268	$	0.02		$	(4,465,210	)		86,526,332	$	(0.05	)

Note_5_Property_and_Equipment_

Note 5 - Property and Equipment, Net	9 Months Ended
	Sep. 30, 2013
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment Disclosure [Text Block]	'
	NOTE 5:                PROPERTY AND EQUIPMENT, NET
	Property and equipment consists of the following:
		30-Sep-13						31-Dec-12
		Cost		Accumulated		Net book		Cost		Accumulated		Net book value		Estimated useful
				depreciation		value				depreciation				life (years)
	Computer & office equipment	$	1,578,095	$	1,288,626	$	289,469	$	1,519,617	$	1,181,451	$	338,166		5
	Leasehold improvements		92,786		73,771		19,015		92,686		68,044		24,642		5
	Computer software		1,549,577		1,459,622		89,955		1,502,524		1,403,705		98,819		3
	Office furniture		114,001		97,229		16,772		110,780		90,604		20,176		5
	Total	$	3,334,459	$	2,919,248	$	415,211	$	3,225,607	$	2,743,804	$	481,803
	Depreciation expense for the nine month periods ended September 30, 2013 and September 30, 2012 was $174,436 and $308,666, respectively.

Note_6_Intangible_Assets_At_Co

Note 6 - Intangible Assets, At Cost	9 Months Ended
	Sep. 30, 2013
Disclosure Text Block [Abstract]	'
Intangible Assets Disclosure [Text Block]	'
	NOTE 6:                INTANGIBLE ASSETS, AT COST
	Intangible assets consist of the following:
		30-Sep-13						31-Dec-12
	Asset	Cost		Accumulated amortization		Net book		Cost		Accumulated amortization		Net book		Estimated useful life (years)
						value						value
	Customer lists	$	1,392,701	$	1,392,701	$	-0-	$	1,392,701	$	1,392,701	$	-0-	3
		$	1,392,701	$	1,392,701	$	-0-	$	1,392,701	$	1,392,701	$	-0-
	Amortization expense was $-0- and $232,117 for the nine month periods ended September 30, 2013 and September 30, 2012, respectively.

Note_7_Accounts_Payable_and_Ac

Note 7 - Accounts Payable and Accrued Expenses	9 Months Ended
	Sep. 30, 2013
Payables and Accruals [Abstract]	'
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	'
	NOTE 7:                ACCOUNTS PAYABLE AND ACCRUED EXPENSES
	Accounts payable and accrued expenses consist of the following:
	Account	30-Sep-13		31-Dec-12
	Accounts payable	$	356,470	$	665,139
	Accrued payroll and related costs		466,420		383,859
	Other accrued expenses		85,094		124,154
	Accrued interest		1,098,196		951,213
	Total accounts payable and accrued expenses	$	2,006,180	$	2,124,365

Note_8_Lines_of_Credit_and_Not

Note 8 - Lines of Credit and Notes Payable	9 Months Ended
	Sep. 30, 2013
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	NOTE 8:                LINES OF CREDIT AND NOTES PAYABLE
	On March 18, 2013, the Company entered into a $2,000,000 revolving line of credit with The Northern Trust Company guaranteed by Cornelis F. Wit, Chief Executive Officer and Director. The line of credit matures on March 17, 2014 and carries a variable interest rate based on the prime rate. At September 30, 2013, $800,000 was outstanding on the line of credit at an interest rate of 2.75%.
	At September 30, 2013, the Company owed $5,667,866 in notes payable all of which are unsecured. The table below provides details as to the terms and conditions of the notes payable.
					Ending
					principal		Non related party				Related party
	Origination	Maturity	Interest		September 30,				Long				Long
	date	date	rate		2013		Current		term		Current		term
	12/31/11	1/1/15		12%	$	1,600,000	$	-0-	$	-0-	$	-0-	$	1,600,000
	4/1/12	1/1/14		12%		17,500		17,500		-0-		-0-		-0-
	12/17/12	12/16/14		12%		20,000		-0-		20,000		-0-		-0-
	1/1/13	1/1/16		12%		529,000		-0-		-0-		-0-		529,000
	1/1/13	1/1/15		10%		308,562		-0-		308,562		-0-		-0-
	1/1/13	1/1/15		10%		123,425		-0-		123,425		-0-		-0-
	1/1/13	1/1/15		12%		45,000		-0-		45,000		-0-		-0-
	2/1/13	1/1/16		12%		20,000		-0-		-0-		-0-		20,000
	3/5/13	1/1/15		12%		137,500		-0-		137,500		-0-		-0-
	4/1/13	3/31/16		12%		2,866,879		-0-		-0-		-0-		2,866,879
	Discount on note payable							-0-		-0-		-0-		(599,916	)
	Total				$	5,667,866	$	17,500	$	634,487	$	-0-	$	4,415,963
	At December 31, 2012, the Company owed $5,138,866 in notes payable all of which were unsecured. The table below provides details as to the terms and conditions of the notes payable.
					Ending
					principal		Non related party				Related party
	Origination	Maturity	Interest		December 31,				Long				Long
	date	date	rate		2012		Current		term		Current		term
	12/31/10	1/1/15		10%	$	308,562	$	-0-	$	308,562	$	-0-	$	-0-
	12/31/10	1/1/15		10%		123,425		-0-		123,425		-0-		-0-
	2/1/11	1/1/15		12%		137,500		-0-		137,500		-0-		-0-
	3/31/11	4/1/14		12%		2,866,879		-0-		-0-		-0-		2,866,879
	12/31/11	1/1/15		12%		1,600,000		-0-		-0-		-0-		1,600,000
	12/31/11	1/1/16		12%		20,000		-0-		-0-		-0-		20,000
	4/1/12	1/1/14		12%		17,500		-0-		17,500		-0-		-0-
	10/1/12	1/1/15		12%		45,000		-0-		45,000		-0-		-0-
	12/17/12	12/16/14		12%		20,000		-0-		20,000		-0-		-0-
	Discount on note payable							-0-		-0-		-0-		(656,524	)
	Total				$	5,138,866	$	-0-	$	651,987	$	-0-	$	3,830,355
	On January 1, 2013, the Company issued a promissory note in the principal amount of $529,000 and warrants to purchase 2,116,000 shares of common stock of the Company at an exercise price of $0.25 per share with an expiration date of January 31, 2016 to our Chief Executive Officer and Director, Cornelis F. Wit. The note carries an interest rate of 12% per annum and is due on January 1, 2016.
	This issuance caused us to calculate and record a derivative liability for the warrant liability. The warrants were valued using the Black Scholes option pricing model. A value of $400,142 was calculated and allocated to the warrants and recorded as a liability to the issuance of the note payable. As a result of the liability we recorded a discount to the note payable. The carrying amount of the note at the time of issuance was therefore $128,858. The warrant liability (discount) will be amortized over the 36 month duration of the note payable. The Company will continue to perform a fair value calculation periodically on the warrant liability and accordingly the warrant liability is increased or decreased based on the fair value calculation. The resulting increase or decrease is reflected in operations as an unrealized gain or loss on changes in derivative liabilities.
	On January 1, 2013 the Company issued promissory notes in the amount of $431,987 in exchange for existing promissory notes in the same amount. The promissory notes carry an interest rate of 10% and have a maturity date of January 1, 2015.
	On January 1, 2013 the Company issued a promissory note in the amount of $45,000 in exchange for an existing promissory note in the same amount. The promissory note carries an interest rate of 12% and has a maturity date of January 1, 2015.
	On February 1, 2013 the Company issued a promissory note in the amount of $20,000 to our Chairman and Chief Technology Officer Randall G. Smith in exchange for an existing promissory note in the same amount. The promissory note carries an interest rate of 12% and has a maturity date of January 1, 2016.
	On March 5, 2013 the Company issued a promissory note in the amount of $137,500 in exchange for a promissory note in the same amount. The promissory note carries an interest rate of 12% and has a maturity date of January 1, 2015.
	On April 1, 2013 the Company issued a promissory note in the amount of $2,866,879 to our Chief Executive Officer Cornelis F. Wit in exchange for an existing promissory note in the same amount. The promissory note carries an interest rate of 12% and has a maturity date of March 31, 2016.

Note_9_Convertible_Notes_Payab

Note 9 - Convertible Notes Payable	9 Months Ended
	Sep. 30, 2013
Convertible Debt Disclosure [Abstract]	'
Convertible Debt Disclosure	'
	NOTE 9:                CONVERTIBLE NOTES PAYABLE
	The following table summarizes the convertible debt outstanding as of September 30, 2013.
																		Carrying amount
																		Short term				Long term
	Date of issuance	Maturity date		Interest rate		Original principal		Principal at September 30,2013		Allocated discount		Total discount amortized		Discount at September 30, 2013		Carrying amount at September 30, 2013			Related	Nonrelated			Related	Nonrelated
	8/1/99	6/30/04			10%	$	862,500	$	75,000	$	-0-	$	-0-	$	-0-	$	75,000	$	-0-	$	75,000	$	-0-	$	-0-
	8/29/08	1/1/15			10%		150,000		150,000		135,600		135,600		-0-		150,000		-0-		-0-		150,000		-0-
	8/29/08	1/1/16			10%		2,120,000		1,770,000		1,916,480		1,916,480		-0-		1,770,000		-0-		-0-		1,770,000		-0-
	12/16/08	12/16/13			12%		160,000		160,000		44,024		44,024		-0-		160,000		160,000		-0-		-0-		-0-
	12/16/08	1/1/14			12%		200,000		200,000		55,030		55,030		-0-		200,000		-0-		200,000		-0-		-0-
	12/16/08	1/1/15			12%		100,000		100,000		27,515		27,515		-0-		100,000		-0-		-0-		-0-		100,000
	12/16/08	1/1/16			12%		4,615,000		4,520,000		1,243,681		1,243,681		-0-		4,520,000		-0-		-0-		4,505,000		15,000
	9/30/09	1/1/16			12%		1,400,000		1,200,000		526,400		526,400		-0-		1,200,000		-0-		-0-		1,100,000		100,000
	12/31/09	1/1/16			12%		1,490,000		1,490,000		935,720		935,720		-0-		1,490,000		-0-		-0-		1,440,000		50,000
	Total					$	11,097,500	$	9,665,000	$	4,884,450	$	4,884,450	$	-0-	$	9,665,000	$	160,000	$	275,000	$	8,965,000	$	265,000
	The following table summarizes the convertible debt outstanding as of December 31, 2012.
																		Carrying amount
																		Short term				Long term
	Date of issuance	Maturitydate		Interest rate		Original principal		Principal at December 31, 2012		Allocated discount		Total discount amortized		Discountat December 31, 2012		Carrying amount at December 31, 2012				Nonrelated				Nonrelated
																			Related				Related
	8/1/99	6/30/04			10%	$	862,500	$	75,000	$	-0-	$	-0-	$	-0-	$	75,000	$	-0-	$	75,000	$	-0-	$	-0-
	8/29/08	1/1/15			10%		150,000		150,000		135,600		135,600		-0-		150,000		-0-		-0-		150,000		-0-
	8/29/08	1/1/16			10%		2,120,000		1,770,000		1,916,480		1,916,480		-0-		1,770,000		-0-		-0-		1,770,000		-0-
	12/16/08	12/16/13			12%		160,000		160,000		44,024		44,024		-0-		160,000		160,000		-0-		-0-		-0-
	12/16/08	1/1/14			12%		200,000		200,000		55,030		55,030		-0-		200,000		-0-		-0-		-0-		200,000
	12/16/08	1/1/15			12%		100,000		100,000		27,515		27,515		-0-		100,000		-0-		-0-		-0-		100,000
	12/16/08	1/1/16			12%		4,615,000		4,520,000		1,243,681		1,243,681		-0-		4,520,000		-0-		-0-		4,505,000		15,000
	9/30/09	1/1/16			12%		1,400,000		1,200,000		526,400		526,400		-0-		1,200,000		-0-		-0-		1,100,000		100,000
	12/31/09	1/1/16			12%		1,490,000		1,490,000		935,720		935,720		-0-		1,490,000		-0-		-0-		1,440,000		50,000
	Total					$	11,097,500	$	9,665,000	$	4,884,450	$	4,884,450	$	-0-	$	9,665,000	$	160,000	$	75,000	$	8,965,000	$	465,000
	10% Convertible Notes
	During 1999, the Company issued 10% Convertible Notes payable in the amount of $862,500 pursuant to a Confidential Private Placement Memorandum. There were costs of $119,625 associated with this offering. The net proceeds to the Company were $742,875. The notes bear interest at ten percent annually, payable semi-annually. The notes were convertible after maturity, which was June 30, 2004, into shares of common stock of the Company at $1.25 per share. As of September 30, 2013, $787,500 of the Convertible Notes had been repaid in cash or converted into 1,495,179 shares of common stock of the Company leaving an outstanding principal balance of $75,000 that is in default. There was $107,858 of accrued interest at September 30, 2013.
	Secured Convertible Debentures
	On September 30, 2009, the Company sold an aggregate of $1,400,000 principal amount 12% Secured Convertible Debentures (the “Debentures”) and common stock purchase warrants (the “Warrants”) to purchase an aggregate of 5,600,000 shares of our common stock exercisable at a price of $0.25 per share for four years subsequent to the closing of the transaction to four accredited investors including our Chief Executive Officer. The Debentures, which bear interest at 12% per annum, matured on March 30, 2011. The Debentures are convertible at any time at the option of the holder into shares of our common stock based upon a conversion rate of $0.25 per share. On March 30, 2011, the Company repaid $200,000 of the outstanding principal amounts owed and extended $1,200,000 of the convertible debentures until April 1, 2013, including $1,100,000 in convertible debentures held by our Chief Executive Officer and Director, Cornelis F. Wit. The Company also extended the expiration date of the warrants associated with the offering until September 30, 2015. On February 22, 2013 the Company and the lenders agreed to extend the maturity date of $1,200,000 of the convertible debentures including $1,100,000 due to our Chief Executive Officer and Director, Cornelis F. Wit to January 1, 2016. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016.
	Convertible Debentures
	On August 29, 2008, the Company sold $2,270,000 of convertible debentures and warrants to purchase an aggregate of 4,540,000 shares of our common stock to four accredited investors including our Chief Executive Officer and one of our Directors. The convertible debentures, which bear interest at 10% per annum, were due on August 29, 2010. The convertible debentures are convertible at any time at the option of the holder into shares of our common stock based upon a conversion rate of $0.50 per share. On September 30, 2009, two Affiliates of the Company extended $1,920,000 of the convertible debentures until August 29, 2013 in accordance with the terms of a Secured Convertible Debenture issued on that date. On February 22, 2013 the Company and Mr. van Kesteren extended the maturity date of $150,000 of the convertible debentures due to our Director, Guus van Kesteren to January 1, 2015. The expiration date of the warrants associated with the debentures was also extended to January 1, 2015. On February 22, 2013 the Company and Mr. Wit extended the maturity date of $1,770,000 of the convertible debentures due to our Chief Executive Officer and Director, Cornelis F. Wit to January 1, 2016. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016.
	On December 16, 2008, we sold $5,075,000 of convertible debentures and warrants to purchase an aggregate of 10,150,000 shares of our common stock to eleven accredited investors including our Chief Executive Officer, Chief Operating Officer, Chief Technology Officer, Chief Financial Officer and four of our Directors. The convertible debentures, which bear interest at 12% per annum, were due on December 16, 2010. The convertible debentures are convertible at any time at the option of the holder into shares of our common stock based upon a conversion rate of $0.50 per share. On September 30, 2009 Affiliates of the Company extended $4,980,000 of Convertible Notes until December 16, 2013 in accordance with the terms of a Secured Convertible Debenture issued on that date. On February 22, 2013 the Company and the lenders agreed to extend the maturity date of $4,505,000 of the convertible debentures including $4,475,000 due to our Chief Executive Officer and Director Cornelis F. Wit, $25,000 due to our Chief Operating Officer and President Stephen E. Johnson and $5,000 due to our Chairman and Chief Technology Officer Randall G. Smith to January 1, 2016. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016. On February 27, 2013 the Company and Mr. Veatch extended the maturity date of $15,000 of convertible debentures issued to our former Director Matthew Veatch to January 1, 2016. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016. On March 6, 2013, the Company and the lenders agreed to extend the maturity date of $200,000 of convertible debentures to January 1, 2014. The expiration date of the warrants associated with the debentures was also extended to January 1, 2014. On March 12, 2013, the Company and the lenders agreed to extend the maturity date of $100,000 of convertible debentures to January 1, 2015. The expiration date of the warrants associated with the debentures was also extended to January 1, 2015.
	On December 31, 2009, the Company sold an aggregate of $1,490,000 principal amount 12% convertible debentures and warrants to purchase an aggregate of 5,960,000 shares of our common stock exercisable at a price of $0.25 per share for four years subsequent to the closing of the transaction to three accredited investors including our Chief Executive Officer. The debentures, which bear interest at 12% per annum, matured on June 30, 2011. The debentures are convertible at any time at the option of the holder into shares of our common stock based upon a conversion rate of $0.25 per share. On June 30, 2011, the Company and the lenders agreed to extend all $1,490,000 of the convertible debentures until October 1, 2013, including $1,440,000 of the Debentures held by our Chief Executive Officer and Director, Cornelis F. Wit. The Company also extended the expiration date of the warrants associated with the December 2009 offering until December 31, 2015. On February 22, 2013 the Company and the lenders agreed to extend the maturity date of all $1,490,000 of the convertible debentures, including $1,440,000 due to our Chief Executive Officer and Director Cornelis F. Wit, to January 1, 2016. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016.
	The payments required at maturity under the Company’s outstanding convertible debt at September 30, 2013 are as follows:
	2013		$	235,000
	2014			200,000
	2015			250,000
	2016			8,980,000
	Total		$	9,665,000

Note_10_Fair_Value_Measurement

Note 10 - Fair Value Measurement	9 Months Ended
	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'
Fair Value Disclosures [Text Block]	'
	NOTE 10:              FAIR VALUE MEASUREMENT
	The Company measures the fair value of its assets and liabilities under the guidance of ASC 820, Fair Value Measurements and Disclosures, which defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value measurements. ASC 820 does not require any new fair value measurements, but its provisions apply to all other accounting pronouncements that require or permit fair value measurement.
	ASC 820 clarifies that fair value is an exit price, representing the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants based on the highest and best use of the asset or liability. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. ASC 820 requires the Company to use valuation techniques to measure fair value that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized as follows:
		●	Level 1: Observable inputs such as quoted prices for identical assets or liabilities in active markets;
		●	Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly such as quoted prices for similar assets or liabilities or market-corroborated inputs; and
		●	Level 3: Unobservable inputs for which there is little or no market data, which require the reporting entity to develop its own assumptions about how market participants would price the assets or liabilities.
	The valuation techniques that may be used to measure fair value are as follows:
		A.	Market approach - Uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities
		B.	Income approach - Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about those future amounts, including present value techniques, option-pricing models and excess earnings method
		C.	Cost approach - Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost)
	The Company also adopted the provisions of ASC 825, Financial Instruments. ASC 825 allows companies to choose to measure eligible assets and liabilities at fair value with changes in value recognized in earnings. Fair value treatment may be elected either upon initial recognition of an eligible asset or liability or, for an existing asset or liability, if an event triggers a new basis of accounting. The Company did not elect to re-measure any of its existing financial assets or liabilities under the provisions of this Statement and did not elect the fair value option for any financial assets and liabilities transacted in the nine month periods ended September 30, 2013 and September 30, 2012.
	The Company’s financial assets or liabilities subject to ASC 820 as of September 30, 2013 include the conversion feature and warrant liability associated with convertible debentures issued during fiscal 2008 and 2009 and the warrants issued during 2011 and 2013 that are associated with notes payable that were issued to our Chief Executive Officer and Director, Cornelis F. Wit. The conversion feature and warrants were deemed to be derivatives (the “Derivative Instruments”) since a fixed conversion price cannot be determined for either of the Derivative Instruments due to anti-dilution provisions embedded in the offering documents for the convertible debentures. The derivative instruments were not issued for risk management purposes and as such are not designated as hedging instruments under the provisions of ASC 815 Disclosures about Derivative Instruments and Hedging Activities. See Note 9 – Convertible Notes Payable.
	Following is a description of the valuation methodologies used to determine the fair value of the Company’s financial assets including the general classification of such instruments pursuant to the valuation hierarchy.
	A summary of the fair value of liabilities measured at fair value on a recurring basis follows:
			Fair value at			Quoted prices in active markets for identical assets/ liabilities			Significant other observable inputs		Significant unobservable inputs
			September 30,
			2013			(Level 1)			(Level 2)		(Level 3)
	Derivatives: (1) (2)
	Conversion feature liability		$	4,024,558		$	-0-		$	-0-	$	4,024,558
	Warrant liability			7,475,176			-0-			-0-		7,475,176
	Total of derivative liabilities		$	11,499,734		$	-0-		$	-0-	$	11,499,734
	(1) The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with the following assumptions for the nine months ended September 30, 2013
	(2) The fair value at the measurement date is equal to their carrying value on the balance sheet
	Significant valuation assumptions of derivative instruments at September 30, 2013
	Risk free interest rate		0.13%
	Dividend yield		0.00%
	Expected volatility	191.87	to	235.24
	Expected life (range in years)
	Conversion feature liability	0.21	to	2.25
	Warrant liability	0.21	to	2.5
	A summary of the fair value of liabilities measured at fair value on a recurring basis follows:
			Fair value at			Quoted prices in active markets for identical assets/ liabilities			Significant other observable inputs		Significant unobservable inputs
			December 31,
			2012			(Level 1)			(Level 2)		(Level 3)
	Derivatives: (1) (2)
	Conversion feature liability		$	2,287,323		$	-0-		$	-0-	$	2,287,323
	Warrant liability			6,287,598			-0-			-0-		6,287,598
	Total of derivative liabilties		$	8,574,921		$	-0-		$	-0-	$	8,574,921
	(1) The fair value of the derivative instruments was estimated using the Black Scholes option pricing model with the following assumptions for the year ended December 31, 2012
	(2) The fair value at the measurement date is equal to their carrying value on the balance sheet
	Significant valuation assumptions of derivative instruments at December 31, 2012
	Risk free interest rate	0.18%	to	0.36%
	Dividend yield		0.00%
	Expected volatility	218.2%	to	259.10%
	Expected life (range in years)
	Conversion feature liability	0.25	to	0.96
	Warrant liability	0.66	to	3.25
			Other income
			for the nine months ended
			30-Sep-13			30-Sep-12
	The net amount of (losses) for the period included in earnings attributable to the unrealized loss from changes in derivative liabilities at the reporting date		$	(2,524,671	)	$	(4,804,260	)
	Total unrealized (losses) included in earnings		$	(2,524,671	)	$	(4,804,260	)
	The tables below set forth a summary of changes in fair value of the Company’s Level 3 financial liabilities at fair value for the periods ended September 30, 2013 and December 31, 2012. The tables reflect changes for all financial liabilities at fair value categorized as Level 3 as of September 30, 2013 and December 31, 2012.
			Level 3 financial assets and financial liabilities at fair value
									Net unrealized
									(gains)/losses
									relating to		Net
									instruments		purchases,
			Balance,						still		issuances		Net transfers		Balance,
			beginning			Net realized			held at the		and		in and/or out		end of
			of year			gains/(losses)			reporting date		settlements		of Level 3		period
	Period ended September 30, 2013
	Derivatives:
Conversion feature liability		$	2,287,323		$	-0-		$	1,737,235	$	-0-	$	-0-	$	4,024,558
Warrant liability			6,287,598			-0-			787,436		400,142		-0-		7,475,176
Total of derivative liabilties		$	8,574,921		$	-0-		$	2,524,671	$	400,142	$	-0-	$	11,499,734
		Level 3 financial assets and financial liabilities at fair value
								Net unrealized
								(gains)/losses
								relating to		Net
								instruments		purchases,
		Balance,						still		issuances		Net transfers		Balance,
		beginning			Net realized			held at the		and		in and/or out		end of
		of year			gains/(losses)			reporting date		settlements		of Level 3		year
Year ended December 31, 2012
Derivatives:
Conversion feature liability		$	758,911		$	-0-		$	1,528,412	$	-0-	$	-0-	$	2,287,323
Warrant liability			1,692,708			-0-			4,594,890		-0-		-0-		6,287,598
Total of derivative liabilties		$	2,451,619		$	-0-		$	6,123,302	$	-0-	$	-0-	$	8,574,921

Note_11_Commitments_and_Contin

Note 11 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	NOTE 11:              COMMITMENTS AND CONTINGENCIES
	The Company currently leases office space under operating leases for its office locations and has several operating leases related to server and network co-location and disaster recovery for its operations. The minimum future lease payments required under the Company’s operating leases at September 30, 2013 are as follows:
		2013		$	146,166
		2014			528,154
		2015			493,130
		2016			270,852
		2017			45,682
		Total		$	1,483,984
	In addition to annual base rental payments, the Company pays for the operating expenses associated with its leased office space and is responsible for any escalation in operating expenses as determined in the leases. Rent expense was $665,932 and $649,424 for the nine month periods ended September 30, 2013 and September 30, 2012, respectively.
	The Company’s corporate office lease expires in September 2016. The Company’s lease on its New Jersey field office expires in February 2016. The Company currently operates its wholly-owned subsidiary, OmniComm Ltd., in the United Kingdom under the terms of a lease that expires in September 2017. The Company currently operates its wholly-owned subsidiary, OmniComm Europe, GmbH, in Germany under the terms of a lease that expires in July 2015.
	LEGAL PROCEEDINGS
	None.
	PATENT LITIGATION SETTLEMENT
	On April 9, 2009, we entered into a Settlement and License Agreement with DataSci, LLC (“DataSci”). DataSci granted us a worldwide, non-exclusive non-transferable right and license under the Licensed Patent and the right to sublicense TrialMaster on a Technology Transfer and Technology Transition basis. Under the terms of the license, we are obligated to pay royalties quarterly for sales of Licensed Products, as defined therein, from January 1, 2009 until the expiration of the Licensed Patent equal to two percent (2%) of OmniComm’s annual Gross Revenues or, alternatively, the annual minimum royalty payment(s), whichever is greater. The remaining minimum royalty payments per year are as follows:
	2013		$	625,000
	2014			450,000
	2015			450,000
	2016			450,000
	2017			450,000
	Total		$	2,425,000
	During the nine month periods ended September 30, 2013 and September 30, 2012 the Company recorded a charge to earnings of $144,972 and $166,442 respectively, which amounts represent (1) the amount of additional license expense incurred above the stipulated minimum in the DataSci License Agreement during the nine month periods ended September 30, 2013 and September 30, 2012 and (2) the accretion of the difference between the total stipulated annual minimum royalty payments and the recorded present value accrual of the annual minimum royalty payments.
	EMPLOYMENT AGREEMENTS
	We have employment agreements in place with the following members of our executive management team:
	Cornelis F. Wit, Chief Executive Officer
	Randall G. Smith, Chief Technology Officer
	Stephen E. Johnson, President and Chief Operating Officer
	The agreements provide, among other things, for participation in employee benefits available to employees and executives. Each of the agreements will renew for successive one-year terms unless the agreement is expressly cancelled by either the employee or the Company ninety days prior to the end of the term. Under the terms of the agreement, we may terminate the employee’s employment upon 30 days notice of a material breach and the employee may terminate the agreement under the same terms and conditions. The employment agreements contain customary non-disclosure and severance provisions, as well as non-compete clauses.

Note_12_Related_Party_Transact

Note 12 - Related Party Transactions	9 Months Ended
	Sep. 30, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
	NOTE 12:              RELATED PARTY TRANSACTIONS
	On February 1, 2013, our Chairman and Chief Technology Officer, Randall Smith extended the maturity date of his $20,000 promissory note until January 1, 2016. The promissory note bears interest at 12% per annum. The note was originally issued on December 16, 2010 with a maturity date of December 31, 2011. On December 31, 2011, Mr. Smith extended the maturity date of his promissory note until April 1, 2013.
	On February 22, 2013, our Director Guus van Kesteren, extended the maturity date of $150,000 of convertible debentures to January 1, 2015. The convertible debentures were originally issued in August 2008. The expiration date of the warrants associated with the debentures was also extended to January 1, 2015.
	On February 22, 2013, our Chief Operating Officer and President, Stephen Johnson extended the maturity date of $25,000 of convertible debentures to January 1, 2016. The convertible debentures were originally issued in December 2008. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016.
	On February 22, 2013, our Chairman and Chief Technology Officer, Randall Smith extended the maturity date of $5,000 of convertible debentures to January 1, 2016. The convertible debentures were originally issued in December 2008. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016.
	As of September 30, 2013, we have an aggregate of $13,780,879 principal amount of convertible debentures and promissory notes outstanding to Cornelis Wit, our Chief Executive Officer and Director, and have issued certain warrants to Mr. Wit, as follows:
		●	In June 2008, Mr. Wit invested $510,000 in convertible notes. On August 29, 2008, Mr. Wit converted the $510,000 and invested an additional $1,260,000 in a private placement of convertible debentures and warrants to purchase 3,540,000 shares of our common stock. The convertible debentures, which bear interest at 10% per annum, were due on August 29, 2010. The convertible debentures are convertible at any time at the option of the holder into shares of our common stock based upon a conversion rate of $0.50 per share. On September 30, 2009, the Company and Mr. Wit extended the $1,770,000 of convertible debentures until August 29, 2013 in accordance with the terms of a Secured Convertible Debenture issued on that date. On February 22, 2013, the Company and Mr. Wit extended the maturity date of the $1,770,000 of convertible debentures to January 1, 2016. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016.
		●	In February 2008, Mr. Wit invested $150,000 in promissory notes and from September 2008 to December 2008, Mr. Wit invested $4,200,000 in convertible notes. On December 16, 2008, Mr. Wit converted the $4,350,000 into a private placement of convertible debentures and warrants to purchase 8,700,000 shares of our common stock. The convertible debentures, which bear interest at 12% per annum, were due on December 16, 2010. The convertible debentures are convertible at any time at the option of the holder into shares of our common stock based upon a conversion rate of $0.50 per share. On September 30, 2009, the Company and Mr. Wit extended the $4,350,000 of convertible debentures until December 16, 2013 in accordance with the terms of a Secured Convertible Debenture issued on that date. In a private transaction on October 16, 2012, Mr. Wit purchased $125,000 of the December 2008 convertible debentures and the related 250,000 warrants from Mr. Ronald Linares, the Company’s former Chief Financial Officer. On February 22, 2013, the Company and Mr. Wit extended the maturity date of the $4,475,000 of convertible debentures to January 1, 2016. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016.
		●	From July 2009 to September 2009, Mr. Wit invested $1,100,000 which amount was aggregated under the terms of one convertible note dated September 30, 2009.  On September 30, 2009, Mr. Wit agreed to convert this convertible note into a private placement of secured convertible debentures bearing interest at a rate of 12% per annum with a maturity date of March 30, 2011. The convertible debentures were convertible into 4,400,000 shares of common stock and Mr. Wit received 4,400,000 warrants to purchase common stock of the Company at a price of $0.25. On March 30, 2011, the Company and Mr. Wit extended the maturity date of his convertible note until April 1, 2013 in accordance with the terms of Amendment Number One To Securities Purchase Agreement. The Company also extended the expiration date of the 4,400,000 warrants issued with convertible note by two years to September 30, 2015. On February 22, 2013, the Company and Mr. Wit extended the maturity date of his convertible debentures to January 1, 2016 in accordance with the terms of Amendment Number Two To Securities Purchase Agreement. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016.
		●	From October 2009 to December 2009, Mr. Wit invested $1,440,000, which amount was aggregated under the terms of one convertible note dated December 31, 2009. On December 31, 2009, Mr. Wit agreed to convert this Convertible Note into a private placement of unsecured convertible debentures bearing interest at a rate of 12% per annum, which Convertible Debentures were due on June 30, 2011. The Company and Mr. Wit extended the maturity date of his convertible note until October 1, 2013 in accordance with the terms of Amendment Number One To Securities Purchase Agreement. The Company also extended the expiration date of the 5,760,000 warrants issued with convertible note by two years to December 31, 2015. On February 22, 2013, the Company and Mr. Wit extended the maturity date of his convertible debentures to January 1, 2016 in accordance with the terms of Amendment Number Two To Securities Purchase Agreement. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016.
		●	On March 31, 2011, the Company issued a note payable in the principal amount of $2,866,879 and warrants to purchase 11,467,517 shares of common stock of the Company at an exercise price of $0.25 per share with an expiration date of March 31, 2016 to our Chief Executive Officer and Director, Cornelis F. Wit. The note accrues interest at a rate of 12% per annum and had a maturity date of April 1, 2014. On April 1, 2013, the Company and Mr. Wit extended the maturity date of the promissory note to March 31, 2016. The Promissory Note replaced the following Promissory Notes that had been previously issued:
	i.		Promissory Note issued on April 13, 2010 for $450,000 with a maturity date of December 31, 2011;
	ii.		Promissory Note issued on June 29, 2010 for $115,000 with a maturity date of December 31, 2011;
	iii.		Promissory Note issued on September 30, 2010 for $695,000 with a maturity date of December 31, 2011;
	iv.		Promissory Note issued on December 31, 2010 for $1,197,500 with a maturity date of December 31, 2011; and
	v.		Promissory Note issued on December 31, 2010 for $409,379 with a maturity date of April 01, 2012.
		●	On December 31, 2011, the Company issued a promissory note in the principal amount of $1,600,000 and warrants to purchase 6,400,000 shares of common stock of the Company at an exercise price of $0.25 per share with an expiration date of December 31, 2015 to our Chief Executive Officer and Director, Cornelis F. Wit. The note carries an interest rate of 12% per annum and is due on January 1, 2015. The promissory note consolidates the amounts owed as detailed below:
	i.		Promissory Note issued on May 13, 2011 for $96,000 with a maturity date of January 01, 2013;
	ii.		Promissory Note issued on September 30, 2011 for $342,000 with a maturity date of April 01, 2014;
	iii.		Promissory Note issued on October 05, 2011 for $130,000 with a maturity date of April 01, 2014;
	iv.		Promissory Note issued on October 28, 2011 for $123,000 with a maturity date of April 01, 2014;
	v.		Promissory Note issued on October 31, 2011 for $82,000 with a maturity date of April 01, 2014;
	vi.		Promissory Note issued on November 23, 2011 for $60,000 with a maturity date of January 1, 2013; and
	vii.		Accrued and unpaid interest in the amount of $767,000.
		●	On January 1, 2013, the Company issued a promissory note in the principal amount of $529,000 and warrants to purchase 2,116,000 shares of common stock of the Company at an exercise price of $0.25 per share with an expiration date of January 31, 2016 to our Chief Executive Officer and Director, Cornelis F. Wit. The note carries an interest rate of 12% per annum and is due on January 1, 2016.
	On March 18, 2013, the Company entered into a $2,000,000 revolving line of credit with The Northern Trust Company guaranteed by Cornelis F. Wit, Chief Executive Officer and Director. The line of credit matures on March 17, 2014 and carries a variable interest rate based on the prime rate.
	For the nine months ended September 30, 2013 and September 30, 2012 we incurred $1,750,327 and $1,573,444, respectively, in interest expense payable to related parties.

Note_13_Stockholders_Deficit

Note 13 - Stockholders' (Deficit)	9 Months Ended
	Sep. 30, 2013
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	NOTE 13:              STOCKHOLDERS’ (DEFICIT)
	Our authorized capital stock consists of 250,000,000 shares of common stock, $.001 par value per share, and 10,000,000 shares of preferred stock, par value $.001 per share, of which 5,000,000 shares have been designated as 5% Series A Preferred Stock, 230,000 shares have been designated as Series B Preferred Stock, 747,500 shares have been designated as Series C Preferred Stock and 250,000 shares have been designated as Series D Preferred Stock.
	As of September 30, 2013 we had the following outstanding securities:
	o     87,834,659 shares of common stock issued and outstanding;
	o     44,728,873 warrants issued and outstanding to purchase shares of our common stock;
	o     4,125,224 shares of our Series A Preferred Stock issued and outstanding,
	o     -0- shares of our Series B Preferred Stock issued and outstanding;
	o     -0- shares of our Series C Preferred Stock issued and outstanding;
	o     250,000 Series D Preferred Stock issued and outstanding; and
	o     $9,665,000 principal amount Convertible Debentures convertible into 24,620,000 shares of common stock.
	Common Stock
	Holders of common stock are entitled to one vote for each share on all matters submitted to a stockholder vote. Holders of our voting securities do not have cumulative voting rights. Holders of common stock are entitled to share in all dividends that the Board of Directors, in its discretion, declares from legally available funds. In the event of our liquidation, dissolution or winding up, subject to the preferences of the Series A Preferred Stockholders, each outstanding share of common stock entitles its holder to participate in all assets that remain after payment of liabilities and after providing for each class of stock, if any, having preference over the common stock.
	Holders of common stock have no conversion, preemptive or other subscription rights, and there are no redemption provisions for the common stock. The rights of the holders of common stock are subject to any rights that may be fixed for holders of preferred stock, when and if any preferred stock is outstanding. All outstanding shares of common stock are duly authorized, validly issued, fully paid and non-assessable.
	Preferred Stock
	Our Board of Directors, without further stockholder approval, may issue preferred stock in one or more series from time to time and fix or alter the designations, relative rights, priorities, preferences, qualifications, limitations and restrictions of the shares of each series. In addition, the Board of Directors may fix and determine all privileges and rights of the authorized preferred stock series including:
	o     dividend and liquidation preferences,
	o     voting rights,
	o     conversion privileges, and
	o     redemption terms.
	Our Board of Directors may authorize the issuance of preferred stock which ranks senior to our common stock for the payment of dividends and the distribution of assets on liquidation. In addition, our Board of Directors can fix limitations and restrictions, if any, upon the payment of dividends on our common stock to be effective while any shares of preferred stock are outstanding.
	The following table presents the cumulative arrearage of undeclared dividends by class of preferred stock as of September 30, 2013 and September 30, 2012, respectively, and the per share amount by class of preferred stock.
			Cumulative arrearage as of								Cumulative arrearage as of
			September 30,								September 30,
	Series of preferred stock		2013				2012				2013				2012
	Series A		$	2,328,450			$	2,122,189			$	0.56			$	0.51
	Series B			609,887				609,887			$	3.05			$	3.05
	Series C			1,472,093				1,472,093			$	4.37			$	4.37
	Total preferred stock arrearage		$	4,410,430			$	4,204,169
	The following table presents preferred dividends accreted for the nine month periods ended September 30, 2013 and September 30, 2012, respectively, and the per share effect of the preferred dividends if their effect was not anti-dilutive.
			Dividends accreted								Dividends per share
			nine months ended September 30,								nine months ended September 30,
			2013				2012				2013				2012
	Preferred stock dividends in arrears Series A		$	154,272			$	177,528			$	0.037			$	0.043
	Preferred stock dividends in arrears Series B		$	-0-			$	-0-			$	-0-			$	-0-
	Preferred stock dividends in arrears Series C		$	-0-			$	-0-			$	-0-			$	-0-
	Warrants Issued for Services and in Capital Transactions
	The following tables summarize all outstanding warrants for the nine month periods ended September 30, 2013 and September 30, 2012, and the related changes during these periods.
	September 30, 2013 warrants outstanding																September 30, 2013 warrants exercisable
	Range of exercise price				Number outstanding at				Weighted average				Weighted average				Number exercisable at			Weighted average
					30-Sep-13				remaining contractual life				exercise price				30-Sep-13			exercise price
	$0.25	-	0.6			44,728,873				2.27			$	0.36				44,728,873		$	0.36
	December 31, 2012 warrants outstanding																	December 31, 2012 warrants exercisable
	Range of exercise price					Number outstanding at				Weighted average				Weighted average				Number exercisable at			Weighted average
						31-Dec-12				remaining contractual life				exercise price				31-Dec-12			exercise price
	$0.25	-	0.6				43,412,873				2.32			$	0.36				43,412,873		$	0.36
	Warrants
	Balance at December 31, 2012			43,412,873
	Issued			2,116,000
	Exercised			-0-
	Expired/forfeited			(800,000	)
	Balance at September 30, 2013			44,728,873
	Warrants exercisable at September 30, 2013			44,728,873
	Weighted average fair value of warrants granted during 2013		$	0.21
	Other Comprehensive (Loss)
	Due to the availability of net operating losses and related deferred tax valuations, there is no tax effect associated with any component of other comprehensive (loss). The following table lists the beginning balance, quarterly activity and ending balance of the components of accumulated other comprehensive (loss).
			Foreign currency				Accumulated other comprehensive (loss)
			translation
	Balance December 31, 2011		$	(53,714	)		$	(53,714	)
	2012 Activity			(15,378	)			(15,378	)
	Balance at December 31, 2012			(69,092	)			(69,092	)
	2013 Activity			(30,485	)			(30,485	)
	Balance at September 30, 2013		$	(99,577	)		$	(99,577	)

Note_14_Employee_Equity_Incent

Note 14 - Employee Equity Incentive Plans	9 Months Ended
	Sep. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	'
	NOTE 14:             EMPLOYEE EQUITY INCENTIVE PLANS
	Stock Option Plan
	Description of 2009 Equity Incentive Plan
	In 2009, the Company’s Board of Directors and shareholders approved the 2009 Equity Incentive Plan of OmniComm Systems, Inc. (the “2009 Plan”). The 2009 Plan provides for granting Incentive Stock Options, Nonqualified Stock Options, Stock Appreciation Rights, Restricted Stock Awards, Phantom Stock Unit Awards and Performance Share Units. Pursuant to the 2009 Plan, 7,500,000 shares of the Company’s common stock are authorized for issuance.
	The maximum term for any option grant under the 2009 Plan is ten years from the date of the grant; however, options granted under the 2009 Plan will generally expire five years from the date of grant for most employees, officers and directors of the Company. Options granted to employees generally vest either upon grant or in two installments. The first vesting, which is equal to 50% of the granted stock options, occurs upon completion of one full year of employment from the date of grant and the second vesting occurs on the second anniversary of the employee’s employment. The vesting period typically begins on the date of hire for new employees and on the date of grant for existing employees. The restrictions on restricted shares granted to employees generally lapse in three equal annual installments on the anniversary of the date of grant.  Any unvested stock options or restricted shares with restrictions that have not lapsed that are granted under the 2009 Plan are forfeited and expire upon termination of employment.
	As of September 30, 2013, there were 3,851,000 outstanding options and 1,225,000 restricted stock shares that have been granted under the 2009 Plan. At September 30, 2013, there were 2,424,000 shares available for grant as options or other forms of share-based compensation under the 2009 Plan.
	Description of 1998 Stock Incentive Plan
	In 1998, the Company’s Board of Directors and shareholders approved the 1998 Stock Incentive Plan of OmniComm Systems, Inc. (the “1998 Plan”). The 1998 Plan provides for granting Incentive Stock Options, Nonqualified Stock Options, Stock Appreciation Rights, Restricted Stock Awards, Phantom Stock Unit Awards and Performance Share Units. Pursuant to the 1998 Plan, 12,500,000 shares of the Company’s common stock were authorized for issuance. The 1998 Plan expired as of December 31, 2008. As of September 30, 2013, there were 2,324,000 outstanding options that have been granted under the 1998 Plan.
	The following table summarizes the stock option activity for the Company’s equity incentive plans:
			Number of				Weighted average exercise price			Weighted average remaining			Aggregate
			shares				(per share)			contractual term			intrinsic value
										(in years)
	Outstanding at December 31, 2011			11,158,000			$	0.37			2.52		$	-0-
	Granted			425,000				0.12
	Exercised			(265,000	)			0.2
	Forfeited/cancelled/expired			(865,500	)			0.43
	Outstanding at December 31, 2012			10,452,500				0.36			1.68		$	149,598
	Granted			200,000				0.18
	Exercised			(100,000	)			0.18
	Forfeited/cancelled/expired			(4,377,500	)			0.43
	Outstanding at September 30, 2013			6,175,000			$	0.3			1.72		$	133,165
	Vested and exercisable at September 30, 2013			5,329,166			$	0.33			1.45		$	82,165
	The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company’s closing stock price at quarter-end and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on September 30, 2013.
	The total number of shares vesting and the fair value of shares vesting for the nine month periods ended September 30, 2013 and September 30, 2012, respectively, was:
			Number of options				Fair value of
			vested				options vested
	Fair value of options vesting during the nine months ended September 30, 2013			593,833			$	62,204
	Fair value of options vesting during the nine months ended September 30, 2012			691,333			$	70,383
	Cash received from stock option exercises for the nine month periods ended September 30, 2013 and September 30, 2012 was $-0- and $-0-, respectively. Due to the Company’s net loss position, no income tax benefit has been realized during the nine month periods ended September 30, 2013 and September 30, 2012.
	The following table summarizes information concerning options outstanding at September 30, 2013:
		Awards breakdown by price range at September 30, 2013
						Outstanding									Vested
	Strike price range ($)					Outstanding			Weighted average remaining			Weighted average outstanding strike price			Vested stock		Weighted average remaining vested contractual life		Weighted average vested strike price
						stock options			contractual life						options
	0.00	to	0.2				3,111,000			2.29		$	0.15			2,365,166		1.97	$	0.16
	0.21	to	0.29				1,025,000			1.44			0.25			925,000		1.08		0.25
	0.30	to	0.49				395,000			0.52			0.46			395,000		0.52		0.46
	0.50	to	0.7				1,644,000			1.12			0.59			1,644,000		1.12		0.59
	0.00	to	0.7				6,175,000			1.72		$	0.3			5,329,166		1.45	$	0.33
	The following table summarizes information concerning options outstanding at December 31, 2012:
		Awards breakdown by price range at December 31, 2012
						Outstanding									Vested
	Strike price range ($)					Outstanding			Weighted average remaining			Weighted average outstanding strike price			Vested stock		Weighted average remaining vested contractual life		Weighted average vested strike price
						stock options			contractual life						options
	0.00	to	0.2				3,428,500			3.02		$	0.15			2,035,083		2.5	$	0.17
	0.21	to	0.29				2,550,000			1.18			0.26			2,550,000		1.18		0.26
	0.30	to	0.49				755,000			0.79			0.45			755,000		0.79		0.45
	0.50	to	0.7				3,719,000			0.97			0.6			3,719,000		0.97		0.6
	0.00	to	0.7				10,452,500			1.68		$	0.36			9,059,083		1.36	$	0.39
	The weighted average fair value (per share) of options granted during the nine month period ended September 30, 2013 was $0.17 and $0.10 during the nine month period ended September 30, 2012. The Black Scholes option-pricing model was utilized to calculate these values.
	Basis for Fair Value Estimate of Share-Based Payments
	Based on analysis of its historical volatility, the Company expects that the future volatility of its share price is likely to be similar to the historical volatility the Company experienced since the Company’s commercialization activities were initiated during the second half of 2000. The Company used a volatility calculation utilizing the Company’s own historical volatility to estimate its future volatility for purposes of valuing the share-based payments that have been granted. Actual volatility, and future changes in estimated volatility, may differ substantially from the Company’s current estimates.
	The Company utilizes the historical data available regarding employee and director exercise activity to calculate an expected life of the options. The table below presents the weighted average expected life in years of options granted under the Plan as described above. The risk-free rate of the stock options is based on the U.S. Treasury yield curve in effect at the time of grant, which corresponds with the expected term of the option granted.
	Below are the assumptions for the fair value of share-based payments for the nine month periods ended September 30, 2013 and September 30, 2012.
			Stock option assumptions for the nine months ended
	Stock option assumptions		30-Sep-13				30-Sep-12
	Risk-free interest rate			0.70%				0.37%
	Expected dividend yield			0.00%				0.00%
	Expected volatility			203.40%				186.60%
	Expected life of options (in years)			5				5
	The following table summarizes weighted average grant date fair value activity for the Company’s incentive stock plans:
			Weighted average grant date fair value
			2013				2012
Stock options granted during the nine month period ended September 30,		$	0.17			$	0.1
Stock options vested during the nine month period ended September 30,		$	0.1			$	0.1
Stock options forfeited during the nine month period ended September 30,		$	0.28			$	0.33
A summary of the status of the Company’s non-vested shares underlying stock options as of September 30, 2013, and changes during the nine month period ended September 30, 2013 is as follows:
		Shares underlying stock options				Weighted average grant date fair value
Nonvested shares at January 1, 2013			1,393,417			$	0.1
Nonvested shares at September 30, 2013			845,834			$	0.12
As of September 30, 2013, approximately $68,959 of total unrecognized compensation cost related to unvested stock options is expected to be recognized over a weighted-average period of 0.8 year.

Note_15_Income_Taxes

Note 15 - Income Taxes	9 Months Ended
	Sep. 30, 2013
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	NOTE 15:              INCOME TAXES
	A reconciliation of income tax expense and the amount computed by applying the statutory federal income tax rate to the income before provision for income taxes is as follows:
		30-Sep-13			30-Sep-12
	Federal statutory rate applied to loss before income taxes	$	(1,662,692	)	$	(2,327,610	)
	Increase/(decrease) in income taxes results from:
	Current tax expense		48,599			54,699
	Non deductible expenses		1,144,767			1,961,459
	Change in deferred assets		37,086			62,632
	Change in valuation allowance		480,839			303,519
	Income tax expense	$	48,599		$	54,699
	The components of income tax expense (benefit) for the nine month periods ended:
		30-Sep-13			30-Sep-12
	Current tax expense:	$	48,599		$	54,699
	Deferred tax expense/(benefit):
	Bad debt allowance		13,106			(47,701	)
	Operating loss carryforward		(531,031	)		(318,450	)
	Patent litigation settlement		37,086			62,632
			(480,839	)		(303,519	)
	Valuation allowance		480,839			303,519
	Total tax expense	$	48,599		$	54,699
	Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets and liabilities are as follows:
		30-Sep-13			30-Sep-12
	Amortization of intangibles	$	283,698		$	283,698
	Bad debt allowance		17,608			100,330
	Patent litigation liability accrual		349,596			401,020
	Operating loss carryforwards		17,887,001			17,238,505
	Gross deferred tax assets		18,537,904			18,023,553
	Valuation allowance		(18,537,904	)		(18,023,553	)
	Net deferred tax liability/(asset)	$	-0-		$	-0-
	The Company has net operating loss carryforwards (NOL) for income tax purposes of approximately $49,779,986. This loss is allowed to be offset against future income until the year 2033 when the NOL’s will expire. Other timing differences relate to depreciation and amortization for the stock acquisition of Education Navigator in 1998. The tax benefits relating to all timing differences have been fully reserved for in the valuation allowance account due to the substantial losses incurred through September 30, 2013. The change in the valuation allowance for the nine month period ended September 30, 2013 was an increase of $480,839.

Note_16_Subsequent_Events

Note 16 - Subsequent Events	9 Months Ended
	Sep. 30, 2013
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	NOTE 16:              SUBSEQUENT EVENTS
	Placeholder for any subsequent events
	On November 11, 2013, with economic effect as of October 31, 2013, we acquired 100% of the capital stock of Promasys B.V., a privately held Netherlands company, from the 4 shareholders of Promasys B.V. pursuant to a share exchange agreement in exchange for 435,998 euros (approximately $593,000) and 2,270,000 shares of our common stock with a fair value of $0.25 per share ($567,500). We issued the 2,270,000 shares to 3 of the shareholders who were all non US- persons / non US- entities and the issuance of the shares to them occurred in an offshore transaction. The issuance of the 2,270,000 shares of common stock to the 3 shareholders of Promasys B.V pursuant to the share exchange agreement was exempt from registration under the Securities Act of 1933, as amended, pursuant to Regulation S thereof.
	Subsequent to September 30, 2013 the Company drew an additional $750,000 on its Line of Credit. The proceeds were primarily used to finance the acquisition of Promasys B.V.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

'

Consolidation, Policy [Policy Text Block]

'

BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION

The Company’s accounts include those of all its wholly-owned subsidiaries, which are more fully described in the Company’s 2012 Annual Report filed on Form 10-K with the Securities and Exchange Commission, and have been prepared in conformity with (i) accounting principles generally accepted in the United States of America; and (ii) the rules and regulations of the United States Securities and Exchange Commission. All significant intercompany accounts and transactions between the Company and its subsidiaries have been eliminated in consolidation.

Basis of Accounting, Policy [Policy Text Block]

'

UNAUDITED FINANCIAL STATEMENTS

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, pursuant to the rules and regulations of the Securities and Exchange Commission. Pursuant to such rules and regulations, certain financial information and footnote disclosures normally included in the consolidated financial statements have been condensed or omitted. The results for the periods indicated are unaudited, but reflect all adjustments (consisting only of normally recurring adjustments) which management considers necessary for a fair presentation of operating results.

The operating results for the three and nine month periods ended September 30, 2013 are not necessarily indicative of the results that may be expected for the year-ended December 31, 2013. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year-ended December 31, 2012.

Use of Estimates, Policy [Policy Text Block]

'

ESTIMATES IN FINANCIAL STATEMENTS

The preparation of the unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Significant estimates incorporated in our financial statements include the recorded allowance for doubtful accounts, the estimate of the appropriate amortization period of our intangible assets, the evaluation of whether our intangible assets have suffered any impairment, the allocation of revenues under multiple-element customer contracts, royalty-based patent liabilities, the value of derivatives associated with debt issued by the Company and the valuation of any corresponding discount to the issuance of our debt. Actual results may differ from those estimates.

Reclassification, Policy [Policy Text Block]

'

Reclassifications

Certain reclassifications have been made in the 2012 financial statements to conform to the 2013 presentation. These reclassifications did not have any effect on our net loss or shareholders’ deficit.

Foreign Currency Transactions and Translations Policy [Policy Text Block]

'

foreign currency translation

The financial statements of the Company’s foreign subsidiaries are translated in accordance with ASC 830-30, Foreign Currency Matters—Translation of Financial Statements. The reporting currency for the Company is the U.S. dollar. The functional currency of the Company’s subsidiaries, OmniComm Europe GmbH in Germany and OmniComm Spain S.L. in Spain is the Euro. The functional currency of the Company’s subsidiary OmniComm Ltd., in the United Kingdom, is the British Pound Sterling. Accordingly, the assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars using the exchange rate in effect at each balance sheet date. Revenue and expense accounts of the Company’s foreign subsidiaries are translated using an average rate of exchange during the period. Foreign currency translation adjustments are accumulated as a component of other comprehensive income/(loss) as a separate component of stockholders’ equity. Gains and losses arising from transactions denominated in foreign currencies are primarily related to intercompany accounts that have been determined to be temporary in nature and accordingly, are recorded directly to the statement of operations. We record translation gains and losses in accumulated other comprehensive income as a component of stockholders’ equity. We recorded translation losses of $30,485 and $10,586 for the nine month periods ended September 30, 2013 and September 30, 2012 respectively.

Revenue Recognition, Policy [Policy Text Block]

'

REVENUE RECOGNITION POLICY

The Company derives revenues from software licenses and services of its EDC products and services which can be purchased on a stand-alone basis. License revenues are derived principally from the sale of term licenses for the following software products offered by the Company: TrialMaster, TrialOne and eClinical Suite (the “EDC Software”). Service revenues are derived principally from the Company's delivery of the hosted solutions of its TrialMaster and eClinical Suite software products, and consulting services and customer support, including training, for all of the Company's products.

The Company recognizes revenues when all of the following conditions are satisfied: (1) there is persuasive evidence of an arrangement; (2) the product or service has been provided to the customer; (3) the collection of fees is probable; and (4) the amount of fees to be paid by the customer is fixed or determinable.

The Company operates in one reportable segment which is the delivery of EDC Software and services to clinical trial sponsors. The Company segregates its revenues based on the activity cycle used to generate its revenues. Accordingly, revenues are currently generated through four main activities, including hosted applications, licensing, professional services and maintenance-related services.

Hosted Application Revenues

The Company offers its TrialMaster and eClinical Suite software products as hosted application solutions delivered through a standard Web-browser, with customer support and training services. The Company's TrialOne solution is presently available only on a licensed basis. To date, hosted applications revenues have been primarily related to TrialMaster.

Revenues resulting from TrialMaster and eClinical Suite application hosting services consist of three components of services for each clinical trial. The first component is comprised of application set up, including design of electronic case report forms and edit checks, installation and server configuration of the system. The second component involves application hosting and related support services as well as billable change orders which consist of amounts billed to customers for functionality changes made. The third stage involves services required to close out, or lock, the database for the clinical trial.

Fees charged and costs incurred for the trial system design, set up and implementation are amortized and recognized ratably over the estimated hosting period. Work performed outside the original scope of work is contracted for separately as an additional fee and is generally recognized ratably over the remaining term of the hosting period. Fees for the first and third stages of the service are billed based upon milestones. Revenues earned upon completion of a contractual milestone are deferred and recognized over the estimated remaining hosting period. Fees for application hosting and related services in the second stage are generally billed quarterly in advance. Revenues resulting from hosting services for the eClinical Suite products consist of installation and server configuration, application hosting and related support services. Services for this offering are generally charged as a fixed fee payable on a quarterly or annual basis. Revenues are recognized ratably over the period of the service.

Licensing Revenues

The Company's software license revenues are earned from the sale of off-the-shelf software. From time-to-time a client might require significant modification or customization subsequent to delivery to the customer. The Company generally enters into software term licenses for its EDC Software products with its customers for three to five year periods, although customers have entered into both longer and shorter term license agreements. These arrangements typically include multiple elements: software license, consulting services and customer support. The Company bills its customers in accordance with the terms of the underlying contract. Generally, the Company bills license fees in advance for each billing cycle of the license term, which typically is either on a quarterly or annual basis. Payment terms are generally net 30 days.

In the past the Company has sold perpetual licenses for EDC Software products in certain situations to existing customers with the option to purchase customer support, and may, in the future, do so for new customers based on customer requirements or market conditions. The Company has established vendor specific objective evidence of fair value for the customer support. Accordingly, license revenues are recognized upon delivery of the software and when all other revenue recognition criteria are met. Customer support revenues are recognized ratably over the term of the underlying support arrangement. The Company generates customer support and maintenance revenues from its perpetual license customer base.

Professional Services

The Company may also enter into arrangements to provide consulting services separate from a license arrangement. In these situations, revenue is recognized on a time-and-materials basis. Professional services can be deemed to be as essential to the functionality of the software at inception and typically are for initial trial configuration, implementation planning, loading of software, building simple interfaces, running test data and documentation of procedures. Subsequent additions or extensions to license terms do not generally include additional professional services.

Pass-through Revenue and Expense

The Company accounts for pass-through revenue and expense in accordance with ASC 605-45, Principal Agent Considerations. In accordance with ASC 605-45, Principal Agent Consideration, these amounts are recorded as revenue in the statement of operations with a corresponding expense recorded in cost of goods sold. Pass-through revenues and expenses include amounts associated with third-party services provided to our customers by our service and product partners. These third-party services are primarily comprised of Interactive Voice and Web Response software services (IVR and IWR), travel and shipping that are incurred on our clients’ behalf.

Maintenance Revenues

Maintenance includes telephone-based help desk support and software maintenance. The Company generally bundles customer support with the software license for the entire term of the arrangement. As a result, the Company generally recognizes revenues for both maintenance and software licenses ratably over the term of the software license and support arrangement. The Company allocates the revenues recognized for these arrangements to the different elements based on management's estimate of the relative fair value of each element. The Company generally invoices each of the elements based on separately quoted amounts and thus has a fairly accurate estimate of the relative fair values of each of the invoiced revenue elements.

Cost of Sales, Policy [Policy Text Block]

'

COST OF REVENUES

Cost of revenues primarily consists of costs related to hosting, maintaining and supporting the Company’s application suite and delivering professional services and support. These costs include salaries, benefits, bonuses and stock-based compensation for the Company’s professional services staff. Cost of revenues also includes outside service provider costs. Cost of revenues is expensed as incurred.

Cash and Cash Equivalents, Policy [Policy Text Block]

'

CASH AND CASH EQUIVALENTS

Cash equivalents consist of highly liquid, short-term investments with maturities of 90 days or less. The carrying amount reported in the accompanying consolidated balance sheets approximates fair value.

Trade and Other Accounts Receivable, Policy [Policy Text Block]

'

ACCOUNTS RECEIVABLE

Accounts receivable are judged as to collectability by management and an allowance for bad debts is established as necessary. The allowance is based on an evaluation of the collectability of accounts receivable and prior bad debt experience. The Company had recorded an allowance for uncollectible accounts receivable of $49,380 as of September 30, 2013 and $84,210 as of December 31, 2012, respectively.

Concentration Risk, Credit Risk, Policy [Policy Text Block]

'

Concentration of Credit Risk

Cash and cash equivalents and restricted cash are deposited with major financial institutions and, at times, such balances with any one financial institution may be in excess of FDIC-insured limits. As of September 30, 2013, $129,390 was deposited in excess of FDIC-insured limits. Management believes the risk in these situations to be minimal.

Except as follows, the Company has no significant off-balance-sheet risk or credit risk concentrations. Financial instruments that subject the Company to potential credit risks are principally cash equivalents and accounts receivable. Concentrated credit risk with respect to accounts receivable is limited to creditworthy customers. The Company's customers are principally located in the United States and Europe. The Company is directly affected by the overall financial condition of the pharmaceutical, biotechnology and medical device industries and management believes that credit risk exists and that any credit risk the Company faces has been adequately reserved for as of September 30, 2013. The Company maintains an allowance for doubtful accounts based on accounts past due according to contractual terms and historical collection experience. Actual losses when incurred are charged to the allowance. The Company's losses related to collection of accounts receivable have consistently been within management's expectations. As of September 30, 2013, the Company believes no additional credit risk exists beyond the amounts provided for in our allowance for uncollectible accounts. The Company evaluates its allowance for uncollectable accounts on a monthly basis based on a specific review of receivable aging and the period that any receivables are beyond the standard payment terms. The Company does not require collateral from its customers in order to mitigate credit risk.

One customer accounted for 11% of our revenues during the nine month period ended September 30, 2013 or approximately $1,221,000 and another customer accounted for 9% or approximately $959,000. One customer accounted for 21% of our revenues during the nine month period ended September 30, 2012 or approximately $2,442,000 and another customer accounted for 17% or approximately $2,043,000. The following table summarizes the number of customers who individually comprise greater than 10% of total revenue and/or total accounts receivable and their aggregate percentage of the Company's total revenue and gross accounts receivable for the periods presented.

Revenues

Accounts receivable

For the period ended

Number of

Percentage of

Number of

Percentage of

customers

total revenues

customers

accounts receivable

30-Sep-13

1

11%

2

29%

31-Dec-12

2

35%

3

54%

30-Sep-12

2

38%

1

13%

The table below provides revenues from European customers for the nine month periods ended September 30, 2013 and September 30, 2012, respectively.

European revenues

For the nine months ended

30-Sep-13

30-Sep-12

European revenues

% of Total revenues

European revenues

% of Total revenues

$

1,214,121

11%

$

1,157,462

10%

The Company serves all of its hosting customers from third-party web hosting facilities located in the United States. The Company does not control the operation of these facilities, and they are vulnerable to damage or interruption. The Company maintains redundant systems that can be used to provide service in the event the third-party web hosting facilities become unavailable, although in such circumstances, the Company's service may be interrupted during the transition.

Property, Plant and Equipment, Policy [Policy Text Block]

'

PROPERTY AND EQUIPMENT

Property and equipment are recorded at cost. Additions and betterments are capitalized; maintenance and repairs are expensed as incurred. Depreciation is calculated using the straight-line method over the asset’s estimated useful life, which is 5 years for leasehold improvements, computers, equipment and furniture and 3 years for software. Gains or losses on disposal are charged to operations.

Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]

'

ASSET IMPAIRMENT

Acquisitions and Intangible Assets

We account for acquisitions in accordance with ASC 805, Business Combinations (“ASC 805”) and ASC 350, Intangibles- Goodwill and Other (“ASC 350”). The acquisition method of accounting requires that assets acquired and liabilities assumed be recorded at their fair values on the date of a business acquisition. Our consolidated financial statements and results of operations reflect an acquired business from the completion date of an acquisition.

The judgments that we make in determining the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact net income in periods following an asset acquisition. We generally use either the income, cost or market approach to aid in our conclusions of such fair values and asset lives. The income approach presumes that the value of an asset can be estimated by the net economic benefit to be received over the life of the asset, discounted to present value. The cost approach presumes that an investor would pay no more for an asset than its replacement or reproduction cost. The market approach estimates value based on what other participants in the market have paid for reasonably similar assets. Although each valuation approach is considered in valuing the assets acquired, the approach ultimately selected is based on the characteristics of the asset and the availability of information.

Long-lived Assets

We review long-lived assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment has occurred typically requires various estimates and assumptions, including determining which cash flows are directly related to the potentially impaired asset, the useful life over which cash flows will occur, their amount and the asset’s residual value, if any. In turn, measurement of an impairment loss requires a determination of fair value, which is based on the best information available. We use quoted market prices when available and independent appraisals and management estimates of future operating cash flows, as appropriate, to determine fair value.

Fair Value of Financial Instruments, Policy [Policy Text Block]

'

FAIR VALUE MEASUREMENT

OmniComm’s capital structure includes the use of warrants and convertible debt features that are classified as derivative financial instruments. Derivative financial instruments are recognized as either assets or liabilities and are measured at fair value under ASC 815 Derivatives and Hedging. ASC 815 requires that changes in the fair value of derivative financial instruments with no hedging designation be recognized as gains/(losses) in the earnings statement. The fair value measurement is determined in accordance with ASC 820 Fair Value Measurements and Disclosures.

Revenue Recognition, Deferred Revenue [Policy Text Block]

'

DEFERRED REVENUE

Deferred revenue represents cash advances and amounts in accounts receivable as of the balance sheet date received in excess of revenue earned on on-going contracts. Payment terms vary with each contract but may include an initial payment at the time the contract is executed, with future payments dependent upon the completion of certain contract phases or targeted milestones. In the event of contract cancellation, the Company is generally entitled to payment for all work performed through the point of cancellation. As of September 30, 2013, the Company had $4,635,964 in deferred revenues relating to contracts for services to be performed over periods ranging from one month to five years. The Company had $3,414,966 in deferred revenues that are expected to be recognized in the next twelve fiscal months.

Advertising Costs, Policy [Policy Text Block]

'

ADVERTISING

Advertising costs are expensed as incurred. Advertising costs were $175,095 and $191,894 for the nine month periods ended September 30, 2013 and September 30, 2012, respectively and are included under selling, general and administrative expenses on our consolidated financial statements.

Research, Development, and Computer Software, Policy [Policy Text Block]

'

RESEARCH AND DEVELOPMENT EXPENSES

Software development costs are included in research and development and are expensed as incurred. ASC 985.20, Software Industry Costs of Software to Be Sold, Leased or Marketed, requires the capitalization of certain development costs of software to be sold once technological feasibility is established, which the Company defines as completion to the point of marketability. The capitalized cost is then amortized on a straight-line basis over the estimated product life. To date, the period between achieving technological feasibility and the general availability of such software has been short and software development costs qualifying for capitalization have been immaterial. Accordingly, the Company has not capitalized any software development costs under ASC 985.20. During the nine month periods ended September 30, 2013 and September 30, 2012 we spent approximately $1,718,079 and $1,867,778 respectively, on research and development activities, which include costs associated with the development of our software products and services for our clients’ projects and which are primarily comprised of salaries and related expenses for our software developers and consulting fees paid to third-party consultants. Research and development costs are primarily included under Salaries, benefits and related taxes in our Statement of Operations.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

'

EMPLOYEE EQUITY INCENTIVE PLANS

The OmniComm Systems, Inc. 2009 Equity Incentive Plan (the “2009 Plan”) was approved at our Annual Meeting of Shareholders on July 10, 2009. The 2009 Plan provides for the issuance of up to 7,500,000 shares to employees, directors and key consultants in accordance with the terms of the 2009 Plan documents. The predecessor plan, the OmniComm Systems, Inc., 1998 Stock Incentive Plan (the “1998 Plan”) expired on December 31, 2008. The 1998 Plan provided for the issuance of up to 12,500,000 shares in accordance with the terms of the 1998 Plan document. Each plan is more fully described in “Note 14, Employee Equity Incentive Plans.” The Company accounts for its employee equity incentive plans under ASC 718, Compensation – Stock Compensation which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions.

ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the Company’s consolidated statements of operations. The Company currently uses the Black Scholes option pricing model to determine grant date fair value.

Earnings Per Share, Policy [Policy Text Block]

'

EARNINGS PER SHARE

The Company accounts for Earnings per Share using ASC 260 – Earnings per Share. Unlike diluted earnings per share, basic earnings per share excludes any dilutive effects of options, warrants, and convertible securities.

Income Tax, Policy [Policy Text Block]

'

INCOME TAXES

The Company accounts for income taxes in accordance with ASC 740, Income Taxes. ASC 740 has as its basic objective the recognition of current and deferred income tax assets and liabilities based upon all events that have been recognized in the financial statements as measured by the provisions of the enacted tax laws.

Valuation allowances are established when necessary to reduce deferred tax assets to the estimated amount to be realized. Income tax expense represents the tax payable for the current period and the change during the period in the deferred tax assets and liabilities.

New Accounting Pronouncements, Policy [Policy Text Block]

'

IMPACT OF NEW ACCOUNTING STANDARDS

During the first nine months of 2013, we adopted the following new accounting pronouncements:

In July 2012, FASB issued Accounting Standards Update 2012-02, Balance Sheet- Intangibles- Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment (“ASU 2012-02”). ASU 2012-002 is an Amendment to FASB Accounting Standards Update 2011-08. The objective of the amendments in this Update is to reduce the cost and complexity of performing an impairment test for indefinite-lived intangible assets by simplifying how an entity tests those assets for impairment and to improve consistency in impairment testing guidance among long-lived asset categories. The amendments permit an entity first to assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test in accordance with Subtopic 350-30, Intangibles—Goodwill and Other—General Intangibles Other than Goodwill. The more-likely-than-not threshold is defined as having a likelihood of more than 50 percent. The amendments are effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. The Company adopted ASU 2012-02 on January 1, 2013, and the adoption did not have a material impact on its consolidated financial position or results of operations.

In February 2013, FASB issued Accounting Standards Update 2013-02, Comprehensive Income (Topic 220) (“ASU 2013-02”). ASU 2013-002 provides guidance on the presentation of amounts reclassified out of accumulated other comprehensive income. This update requires an entity to provide information about the amounts reclassified from accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in the notes, significant amounts reclassified from accumulated other comprehensive income by the net income line item. The Company adopted ASU 2013-02 as of January 1, 2013, and the adoption did not have a material impact on its consolidated financial position or results of operations.

Accounting standards-setting organizations frequently issue new or revised accounting rules. We regularly review all new pronouncements to determine their impact, if any, on our financial statements.

Note_2_Summary_of_Significant_1

Note 2 - Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]	'
Revenue Recognition, Multiple-deliverable Arrangements [Table Text Block]	'
			For the nine months ended
	Revenue activity		30-Sep-13				30-Sep-12
	Set-up fees		$	2,584,285			$	4,085,437
	Change orders			344,400				202,498
	Maintenance			3,495,908				3,928,079
	Software licenses			2,333,016				2,525,933
	Professional services			1,625,600				638,302
	Hosting			572,935				517,239
	Total		$	10,956,144			$	11,897,488
			For the three months ended
	Revenue activity		30-Sep-13				30-Sep-12
	Set-up fees		$	988,990			$	1,458,304
	Change orders			119,870				48,417
	Maintenance			1,186,023				1,307,547
	Software licenses			430,323				847,297
	Professional services			552,719				213,187
	Hosting			199,696				183,568
	Total		$	3,477,621			$	4,058,320
Allowance for Credit Losses on Financing Receivables [Table Text Block]	'
			30-Sep-13				31-Dec-12
	Beginning of period		$	84,210			$	142,444
	Bad debt expense			(4,830	)			(58,234	)
	Write-offs			(30,000	)			-0-
	End of period		$	49,380			$	84,210
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	'
			Revenues								Accounts receivable
	For the period ended		Number of				Percentage of				Number of			Percentage of
			customers				total revenues				customers			accounts receivable
	30-Sep-13			1				11%				2			29%
	31-Dec-12			2				35%				3			54%
	30-Sep-12			2				38%				1			13%
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]	'
		European revenues
		For the nine months ended
		30-Sep-13								30-Sep-12
		European revenues				% of Total revenues				European revenues			% of Total revenues
		$	1,214,121				11%			$	1,157,462			10%

Note_4_Earnings_Loss_Per_Share1

Note 4 - Earnings (Loss) Per Share (Tables)	9 Months Ended
	Sep. 30, 2013
Earnings Per Share [Abstract]	'
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	'
	Anti-dilutive security	30-Sep-13			30-Sep-12
	Preferred stock		2,750,149			2,750,149
	Employee stock options		6,175,000			10,502,500
	Warrants		44,728,873			44,089,580
	Convertible notes		24,620,000			24,620,000
	Shares issuable for accrued interest		1,228,598			559,280
	Total		79,502,620			82,521,509
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'
	For the nine months ended
		30-Sep-13								30-Sep-12
		Income (loss)			Shares		Per-share			Income (loss)			Shares		Per-share
		numerator			denominator		amount			numerator			denominator		amount
	Basic EPS	$	(4,621,397	)		87,515,641	$	(0.05	)	$	(6,417,743	)		86,496,550	$	(0.07	)
	Effect of dilutive securities
	None		-0-			-0-		-0-			-0-			-0-		-0-
	Diluted EPS	$	(4,621,397	)		87,515,641	$	(0.05	)	$	(6,417,743	)		86,496,550	$	(0.07	)
	For the three months ended
		30-Sep-13								30-Sep-12
		Income (loss)			Shares		Per-share			Income (loss)			Shares		Per-share
		numerator			denominator		amount			numerator			denominator		amount
	Basic EPS	$	1,680,481			87,867,268	$	0.02		$	(4,465,210	)		86,526,332	$	(0.05	)
	Effect of dilutive securities
	None		-0-			-0-		-0-			-0-			-0-		-0-
	Diluted EPS	$	1,680,481			87,867,268	$	0.02		$	(4,465,210	)		86,526,332	$	(0.05	)

Note_5_Property_and_Equipment_1

Note 5 - Property and Equipment, Net (Tables)	9 Months Ended
	Sep. 30, 2013
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment [Table Text Block]	'
		30-Sep-13						31-Dec-12
		Cost		Accumulated		Net book		Cost		Accumulated		Net book value		Estimated useful
				depreciation		value				depreciation				life (years)
	Computer & office equipment	$	1,578,095	$	1,288,626	$	289,469	$	1,519,617	$	1,181,451	$	338,166		5
	Leasehold improvements		92,786		73,771		19,015		92,686		68,044		24,642		5
	Computer software		1,549,577		1,459,622		89,955		1,502,524		1,403,705		98,819		3
	Office furniture		114,001		97,229		16,772		110,780		90,604		20,176		5
	Total	$	3,334,459	$	2,919,248	$	415,211	$	3,225,607	$	2,743,804	$	481,803

Note_6_Intangible_Assets_At_Co1

Note 6 - Intangible Assets, At Cost (Tables)	9 Months Ended
	Sep. 30, 2013
Disclosure Text Block [Abstract]	'
Schedule of Finite-Lived Intangible Assets [Table Text Block]	'
		30-Sep-13						31-Dec-12
	Asset	Cost		Accumulated amortization		Net book		Cost		Accumulated amortization		Net book		Estimated useful life (years)
						value						value
	Customer lists	$	1,392,701	$	1,392,701	$	-0-	$	1,392,701	$	1,392,701	$	-0-	3
		$	1,392,701	$	1,392,701	$	-0-	$	1,392,701	$	1,392,701	$	-0-

Note_7_Accounts_Payable_and_Ac1

Note 7 - Accounts Payable and Accrued Expenses (Tables)	9 Months Ended
	Sep. 30, 2013
Payables and Accruals [Abstract]	'
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	'
	Account	30-Sep-13		31-Dec-12
	Accounts payable	$	356,470	$	665,139
	Accrued payroll and related costs		466,420		383,859
	Other accrued expenses		85,094		124,154
	Accrued interest		1,098,196		951,213
	Total accounts payable and accrued expenses	$	2,006,180	$	2,124,365

Note_8_Lines_of_Credit_and_Not1

Note 8 - Lines of Credit and Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2013
Debt Disclosure [Abstract]	'
Schedule of Debt [Table Text Block]	'
					Ending
					principal		Non related party				Related party
	Origination	Maturity	Interest		September 30,				Long				Long
	date	date	rate		2013		Current		term		Current		term
	12/31/11	1/1/15		12%	$	1,600,000	$	-0-	$	-0-	$	-0-	$	1,600,000
	4/1/12	1/1/14		12%		17,500		17,500		-0-		-0-		-0-
	12/17/12	12/16/14		12%		20,000		-0-		20,000		-0-		-0-
	1/1/13	1/1/16		12%		529,000		-0-		-0-		-0-		529,000
	1/1/13	1/1/15		10%		308,562		-0-		308,562		-0-		-0-
	1/1/13	1/1/15		10%		123,425		-0-		123,425		-0-		-0-
	1/1/13	1/1/15		12%		45,000		-0-		45,000		-0-		-0-
	2/1/13	1/1/16		12%		20,000		-0-		-0-		-0-		20,000
	3/5/13	1/1/15		12%		137,500		-0-		137,500		-0-		-0-
	4/1/13	3/31/16		12%		2,866,879		-0-		-0-		-0-		2,866,879
	Discount on note payable							-0-		-0-		-0-		(599,916	)
	Total				$	5,667,866	$	17,500	$	634,487	$	-0-	$	4,415,963
					Ending
					principal		Non related party				Related party
	Origination	Maturity	Interest		December 31,				Long				Long
	date	date	rate		2012		Current		term		Current		term
	12/31/10	1/1/15		10%	$	308,562	$	-0-	$	308,562	$	-0-	$	-0-
	12/31/10	1/1/15		10%		123,425		-0-		123,425		-0-		-0-
	2/1/11	1/1/15		12%		137,500		-0-		137,500		-0-		-0-
	3/31/11	4/1/14		12%		2,866,879		-0-		-0-		-0-		2,866,879
	12/31/11	1/1/15		12%		1,600,000		-0-		-0-		-0-		1,600,000
	12/31/11	1/1/16		12%		20,000		-0-		-0-		-0-		20,000
	4/1/12	1/1/14		12%		17,500		-0-		17,500		-0-		-0-
	10/1/12	1/1/15		12%		45,000		-0-		45,000		-0-		-0-
	12/17/12	12/16/14		12%		20,000		-0-		20,000		-0-		-0-
	Discount on note payable							-0-		-0-		-0-		(656,524	)
	Total				$	5,138,866	$	-0-	$	651,987	$	-0-	$	3,830,355

Note_9_Convertible_Notes_Payab1

Note 9 - Convertible Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2013
Note 9 - Convertible Notes Payable (Tables) [Line Items]	'
Schedule of Maturities of Long-term Debt [Table Text Block]	'
	2013		$	235,000
	2014			200,000
	2015			250,000
	2016			8,980,000
	Total		$	9,665,000
Convertible Debt [Member]	'
Note 9 - Convertible Notes Payable (Tables) [Line Items]	'
Schedule of Long-term Debt Instruments [Table Text Block]	'
																		Carrying amount
																		Short term				Long term
	Date of issuance	Maturity date		Interest rate		Original principal		Principal at September 30,2013		Allocated discount		Total discount amortized		Discount at September 30, 2013		Carrying amount at September 30, 2013			Related	Nonrelated			Related	Nonrelated
	8/1/99	6/30/04			10%	$	862,500	$	75,000	$	-0-	$	-0-	$	-0-	$	75,000	$	-0-	$	75,000	$	-0-	$	-0-
	8/29/08	1/1/15			10%		150,000		150,000		135,600		135,600		-0-		150,000		-0-		-0-		150,000		-0-
	8/29/08	1/1/16			10%		2,120,000		1,770,000		1,916,480		1,916,480		-0-		1,770,000		-0-		-0-		1,770,000		-0-
	12/16/08	12/16/13			12%		160,000		160,000		44,024		44,024		-0-		160,000		160,000		-0-		-0-		-0-
	12/16/08	1/1/14			12%		200,000		200,000		55,030		55,030		-0-		200,000		-0-		200,000		-0-		-0-
	12/16/08	1/1/15			12%		100,000		100,000		27,515		27,515		-0-		100,000		-0-		-0-		-0-		100,000
	12/16/08	1/1/16			12%		4,615,000		4,520,000		1,243,681		1,243,681		-0-		4,520,000		-0-		-0-		4,505,000		15,000
	9/30/09	1/1/16			12%		1,400,000		1,200,000		526,400		526,400		-0-		1,200,000		-0-		-0-		1,100,000		100,000
	12/31/09	1/1/16			12%		1,490,000		1,490,000		935,720		935,720		-0-		1,490,000		-0-		-0-		1,440,000		50,000
	Total					$	11,097,500	$	9,665,000	$	4,884,450	$	4,884,450	$	-0-	$	9,665,000	$	160,000	$	275,000	$	8,965,000	$	265,000
																		Carrying amount
																		Short term				Long term
	Date of issuance	Maturitydate		Interest rate		Original principal		Principal at December 31, 2012		Allocated discount		Total discount amortized		Discountat December 31, 2012		Carrying amount at December 31, 2012				Nonrelated				Nonrelated
																			Related				Related
	8/1/99	6/30/04			10%	$	862,500	$	75,000	$	-0-	$	-0-	$	-0-	$	75,000	$	-0-	$	75,000	$	-0-	$	-0-
	8/29/08	1/1/15			10%		150,000		150,000		135,600		135,600		-0-		150,000		-0-		-0-		150,000		-0-
	8/29/08	1/1/16			10%		2,120,000		1,770,000		1,916,480		1,916,480		-0-		1,770,000		-0-		-0-		1,770,000		-0-
	12/16/08	12/16/13			12%		160,000		160,000		44,024		44,024		-0-		160,000		160,000		-0-		-0-		-0-
	12/16/08	1/1/14			12%		200,000		200,000		55,030		55,030		-0-		200,000		-0-		-0-		-0-		200,000
	12/16/08	1/1/15			12%		100,000		100,000		27,515		27,515		-0-		100,000		-0-		-0-		-0-		100,000
	12/16/08	1/1/16			12%		4,615,000		4,520,000		1,243,681		1,243,681		-0-		4,520,000		-0-		-0-		4,505,000		15,000
	9/30/09	1/1/16			12%		1,400,000		1,200,000		526,400		526,400		-0-		1,200,000		-0-		-0-		1,100,000		100,000
	12/31/09	1/1/16			12%		1,490,000		1,490,000		935,720		935,720		-0-		1,490,000		-0-		-0-		1,440,000		50,000
	Total					$	11,097,500	$	9,665,000	$	4,884,450	$	4,884,450	$	-0-	$	9,665,000	$	160,000	$	75,000	$	8,965,000	$	465,000

Note_10_Fair_Value_Measurement1

Note 10 - Fair Value Measurement (Tables)	9 Months Ended
	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]	'
	A summary of the fair value of liabilities measured at fair value on a recurring basis follows:
			Fair value at			Quoted prices in active markets for identical assets/ liabilities			Significant other observable inputs		Significant unobservable inputs
			September 30,
			2013			(Level 1)			(Level 2)		(Level 3)
	Derivatives: (1) (2)
	Conversion feature liability		$	4,024,558		$	-0-		$	-0-	$	4,024,558
	Warrant liability			7,475,176			-0-			-0-		7,475,176
	Total of derivative liabilities		$	11,499,734		$	-0-		$	-0-	$	11,499,734
	A summary of the fair value of liabilities measured at fair value on a recurring basis follows:
			Fair value at			Quoted prices in active markets for identical assets/ liabilities			Significant other observable inputs		Significant unobservable inputs
			December 31,
			2012			(Level 1)			(Level 2)		(Level 3)
	Derivatives: (1) (2)
	Conversion feature liability		$	2,287,323		$	-0-		$	-0-	$	2,287,323
	Warrant liability			6,287,598			-0-			-0-		6,287,598
	Total of derivative liabilties		$	8,574,921		$	-0-		$	-0-	$	8,574,921
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]	'
	Significant valuation assumptions of derivative instruments at September 30, 2013
	Risk free interest rate		0.13%
	Dividend yield		0.00%
	Expected volatility	191.87	to	235.24
	Expected life (range in years)
	Conversion feature liability	0.21	to	2.25
	Warrant liability	0.21	to	2.5
	Significant valuation assumptions of derivative instruments at December 31, 2012
	Risk free interest rate	0.18%	to	0.36%
	Dividend yield		0.00%
	Expected volatility	218.2%	to	259.10%
	Expected life (range in years)
	Conversion feature liability	0.25	to	0.96
	Warrant liability	0.66	to	3.25
Schedule of Derivative Liabilities at Fair Value [Table Text Block]	'
			Other income
			for the nine months ended
			30-Sep-13			30-Sep-12
	The net amount of (losses) for the period included in earnings attributable to the unrealized loss from changes in derivative liabilities at the reporting date		$	(2,524,671	)	$	(4,804,260	)
	Total unrealized (losses) included in earnings		$	(2,524,671	)	$	(4,804,260	)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	'
			Level 3 financial assets and financial liabilities at fair value
									Net unrealized
									(gains)/losses
									relating to		Net
									instruments		purchases,
			Balance,						still		issuances		Net transfers		Balance,
			beginning			Net realized			held at the		and		in and/or out		end of
			of year			gains/(losses)			reporting date		settlements		of Level 3		period
	Period ended September 30, 2013
	Derivatives:
	Conversion feature liability		$	2,287,323		$	-0-		$	1,737,235	$	-0-	$	-0-	$	4,024,558
	Warrant liability			6,287,598			-0-			787,436		400,142		-0-		7,475,176
	Total of derivative liabilties		$	8,574,921		$	-0-		$	2,524,671	$	400,142	$	-0-	$	11,499,734
			Level 3 financial assets and financial liabilities at fair value
									Net unrealized
									(gains)/losses
									relating to		Net
									instruments		purchases,
			Balance,						still		issuances		Net transfers		Balance,
			beginning			Net realized			held at the		and		in and/or out		end of
			of year			gains/(losses)			reporting date		settlements		of Level 3		year
	Year ended December 31, 2012
	Derivatives:
	Conversion feature liability		$	758,911		$	-0-		$	1,528,412	$	-0-	$	-0-	$	2,287,323
	Warrant liability			1,692,708			-0-			4,594,890		-0-		-0-		6,287,598
	Total of derivative liabilties		$	2,451,619		$	-0-		$	6,123,302	$	-0-	$	-0-	$	8,574,921

Note_11_Commitments_and_Contin1

Note 11 - Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	'
		2013		$	146,166
		2014			528,154
		2015			493,130
		2016			270,852
		2017			45,682
		Total		$	1,483,984
Schedule of Minimum Royalty Payments [Table Text Block]	'
	2013		$	625,000
	2014			450,000
	2015			450,000
	2016			450,000
	2017			450,000
	Total		$	2,425,000

Note_13_Stockholders_Deficit_T

Note 13 - Stockholders' (Deficit) (Tables)	9 Months Ended
	Sep. 30, 2013
Note 13 - Stockholders' (Deficit) (Tables) [Line Items]	'
Schedule of Dividends in Arrears [Table Text Block]	'
			Cumulative arrearage as of								Cumulative arrearage as of
			September 30,								September 30,
	Series of preferred stock		2013				2012				2013				2012
	Series A		$	2,328,450			$	2,122,189			$	0.56			$	0.51
	Series B			609,887				609,887			$	3.05			$	3.05
	Series C			1,472,093				1,472,093			$	4.37			$	4.37
	Total preferred stock arrearage		$	4,410,430			$	4,204,169
Schedule of Dividends Payable [Table Text Block]	'
			Dividends accreted								Dividends per share
			nine months ended September 30,								nine months ended September 30,
			2013				2012				2013				2012
	Preferred stock dividends in arrears Series A		$	154,272			$	177,528			$	0.037			$	0.043
	Preferred stock dividends in arrears Series B		$	-0-			$	-0-			$	-0-			$	-0-
	Preferred stock dividends in arrears Series C		$	-0-			$	-0-			$	-0-			$	-0-
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	'
	September 30, 2013 warrants outstanding																September 30, 2013 warrants exercisable
	Range of exercise price				Number outstanding at				Weighted average				Weighted average				Number exercisable at			Weighted average
					30-Sep-13				remaining contractual life				exercise price				30-Sep-13			exercise price
	$0.25	-	0.6			44,728,873				2.27			$	0.36				44,728,873		$	0.36
	December 31, 2012 warrants outstanding																	December 31, 2012 warrants exercisable
	Range of exercise price					Number outstanding at				Weighted average				Weighted average				Number exercisable at			Weighted average
						31-Dec-12				remaining contractual life				exercise price				31-Dec-12			exercise price
	$0.25	-	0.6				43,412,873				2.32			$	0.36				43,412,873		$	0.36
Schedule of Share-based Compensation, Activity [Table Text Block]	'
			Weighted average grant date fair value
			2013				2012
	Stock options granted during the nine month period ended September 30,		$	0.17			$	0.1
	Stock options vested during the nine month period ended September 30,		$	0.1			$	0.1
	Stock options forfeited during the nine month period ended September 30,		$	0.28			$	0.33
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	'
			Foreign currency				Accumulated other comprehensive (loss)
			translation
	Balance December 31, 2011		$	(53,714	)		$	(53,714	)
	2012 Activity			(15,378	)			(15,378	)
	Balance at December 31, 2012			(69,092	)			(69,092	)
	2013 Activity			(30,485	)			(30,485	)
	Balance at September 30, 2013		$	(99,577	)		$	(99,577	)
Warrant [Member]	'
Note 13 - Stockholders' (Deficit) (Tables) [Line Items]	'
Schedule of Share-based Compensation, Activity [Table Text Block]	'
	Warrants
	Balance at December 31, 2012			43,412,873
	Issued			2,116,000
	Exercised			-0-
	Expired/forfeited			(800,000	)
	Balance at September 30, 2013			44,728,873
	Warrants exercisable at September 30, 2013			44,728,873
	Weighted average fair value of warrants granted during 2013		$	0.21

Note_14_Employee_Equity_Incent1

Note 14 - Employee Equity Incentive Plans (Tables)	9 Months Ended
	Sep. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
			Number of				Weighted average exercise price			Weighted average remaining			Aggregate
			shares				(per share)			contractual term			intrinsic value
										(in years)
	Outstanding at December 31, 2011			11,158,000			$	0.37			2.52		$	-0-
	Granted			425,000				0.12
	Exercised			(265,000	)			0.2
	Forfeited/cancelled/expired			(865,500	)			0.43
	Outstanding at December 31, 2012			10,452,500				0.36			1.68		$	149,598
	Granted			200,000				0.18
	Exercised			(100,000	)			0.18
	Forfeited/cancelled/expired			(4,377,500	)			0.43
	Outstanding at September 30, 2013			6,175,000			$	0.3			1.72		$	133,165
	Vested and exercisable at September 30, 2013			5,329,166			$	0.33			1.45		$	82,165
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	'
			Number of options				Fair value of
			vested				options vested
	Fair value of options vesting during the nine months ended September 30, 2013			593,833			$	62,204
	Fair value of options vesting during the nine months ended September 30, 2012			691,333			$	70,383
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	'
		Awards breakdown by price range at September 30, 2013
						Outstanding									Vested
	Strike price range ($)					Outstanding			Weighted average remaining			Weighted average outstanding strike price			Vested stock		Weighted average remaining vested contractual life		Weighted average vested strike price
						stock options			contractual life						options
	0.00	to	0.2				3,111,000			2.29		$	0.15			2,365,166		1.97	$	0.16
	0.21	to	0.29				1,025,000			1.44			0.25			925,000		1.08		0.25
	0.30	to	0.49				395,000			0.52			0.46			395,000		0.52		0.46
	0.50	to	0.7				1,644,000			1.12			0.59			1,644,000		1.12		0.59
	0.00	to	0.7				6,175,000			1.72		$	0.3			5,329,166		1.45	$	0.33
		Awards breakdown by price range at December 31, 2012
						Outstanding									Vested
	Strike price range ($)					Outstanding			Weighted average remaining			Weighted average outstanding strike price			Vested stock		Weighted average remaining vested contractual life		Weighted average vested strike price
						stock options			contractual life						options
	0.00	to	0.2				3,428,500			3.02		$	0.15			2,035,083		2.5	$	0.17
	0.21	to	0.29				2,550,000			1.18			0.26			2,550,000		1.18		0.26
	0.30	to	0.49				755,000			0.79			0.45			755,000		0.79		0.45
	0.50	to	0.7				3,719,000			0.97			0.6			3,719,000		0.97		0.6
	0.00	to	0.7				10,452,500			1.68		$	0.36			9,059,083		1.36	$	0.39
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	'
			Stock option assumptions for the nine months ended
	Stock option assumptions		30-Sep-13				30-Sep-12
	Risk-free interest rate			0.70%				0.37%
	Expected dividend yield			0.00%				0.00%
	Expected volatility			203.40%				186.60%
	Expected life of options (in years)			5				5
Schedule of Share-based Compensation, Activity [Table Text Block]	'
			Weighted average grant date fair value
			2013				2012
	Stock options granted during the nine month period ended September 30,		$	0.17			$	0.1
	Stock options vested during the nine month period ended September 30,		$	0.1			$	0.1
	Stock options forfeited during the nine month period ended September 30,		$	0.28			$	0.33
Schedule of Nonvested Share Activity [Table Text Block]	'
			Shares underlying stock options				Weighted average grant date fair value
	Nonvested shares at January 1, 2013			1,393,417			$	0.1
	Nonvested shares at September 30, 2013			845,834			$	0.12

Note_15_Income_Taxes_Tables

Note 15 - Income Taxes (Tables)	9 Months Ended
	Sep. 30, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	'
		30-Sep-13			30-Sep-12
	Federal statutory rate applied to loss before income taxes	$	(1,662,692	)	$	(2,327,610	)
	Increase/(decrease) in income taxes results from:
	Current tax expense		48,599			54,699
	Non deductible expenses		1,144,767			1,961,459
	Change in deferred assets		37,086			62,632
	Change in valuation allowance		480,839			303,519
	Income tax expense	$	48,599		$	54,699
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	'
		30-Sep-13			30-Sep-12
	Current tax expense:	$	48,599		$	54,699
	Deferred tax expense/(benefit):
	Bad debt allowance		13,106			(47,701	)
	Operating loss carryforward		(531,031	)		(318,450	)
	Patent litigation settlement		37,086			62,632
			(480,839	)		(303,519	)
	Valuation allowance		480,839			303,519
	Total tax expense	$	48,599		$	54,699
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'
		30-Sep-13			30-Sep-12
	Amortization of intangibles	$	283,698		$	283,698
	Bad debt allowance		17,608			100,330
	Patent litigation liability accrual		349,596			401,020
	Operating loss carryforwards		17,887,001			17,238,505
	Gross deferred tax assets		18,537,904			18,023,553
	Valuation allowance		(18,537,904	)		(18,023,553	)
	Net deferred tax liability/(asset)	$	-0-		$	-0-

Note_1_Organization_and_Nature1

Note 1 - Organization and Nature of Operations (Details) (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Disclosure Text Block [Abstract]	'	'
Research and Development Expense (in Dollars)	$1,718,079	$1,867,778

Note_2_Summary_of_Significant_2

Note 2 - Summary of Significant Accounting Policies (Details) (USD $)

3 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

9 Months Ended

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2013

Jul. 10, 2009

Sep. 30, 2013

Sep. 30, 2013

Customer 1 [Member]

Customer 2 [Member]

Customer 3 [Member]

Customer 4 [Member]

Leasehold Improvements, Computers, Equipment and Furniture [Member]

Software and Software Development Costs [Member]

2009 Plan [Member]

Minimum [Member]

Maximum [Member]

Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (in Dollars)

($3,006)

($3,398)

($30,485)

($10,586)

($15,378)

'

'

'

'

'

'

'

'

'

Term of Software License

'

'

'

'

'

'

'

'

'

'

'

'

'3 years

'5 years

Allowance for Doubtful Accounts Receivable, Current (in Dollars)

49,380

'

49,380

'

84,210

'

'

'

'

'

'

'

'

'

Cash, Uninsured Amount (in Dollars)

129,390

'

129,390

'

'

'

'

'

'

'

'

'

'

'

Concentration Risk, Percentage

'

'

'

'

'

11.00%

9.00%

21.00%

17.00%

'

'

'

'

'

Revenues (in Dollars)

3,477,621

4,058,320

10,956,144

11,897,488

'

1,221,000

959,000

2,442,000

2,043,000

'

'

'

'

'

Property, Plant and Equipment, Useful Life

'

'

'

'

'

'

'

'

'

'5 years

'3 years

'

'

'

Deferred Revenue (in Dollars)

4,635,964

'

4,635,964

'

'

'

'

'

'

'

'

'

'

'

Derivative, Term of Contract

'

'

'

'

'

'

'

'

'

'

'

'

'1 month

'5 years

Deferred Revenue, Current (in Dollars)

3,414,966

'

3,414,966

'

3,732,240

'

'

'

'

'

'

'

'

'

Advertising Expense (in Dollars)

'

'

175,095

191,894

'

'

'

'

'

'

'

'

'

'

Research and Development Expense (in Dollars)

'

'

$1,718,079

$1,867,778

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)

'

'

'

'

'

'

'

'

'

'

'

7,500,000

'

'

Note_2_Summary_of_Significant_3

Note 2 - Summary of Significant Accounting Policies (Details) - Revenue By Business Activity (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]	'	'	'	'
Revenues (in Dollars)	$3,477,621	$4,058,320	$10,956,144	$11,897,488
Set-up Fees [Member]	'	'	'	'
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]	'	'	'	'
Revenues (in Dollars)	988,990	1,458,304	2,584,285	4,085,437
Change Orders [Member]	'	'	'	'
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]	'	'	'	'
Revenues (in Dollars)	119,870	48,417	344,400	202,498
Maintenance [Member]	'	'	'	'
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]	'	'	'	'
Revenues (in Dollars)	1,186,023	1,307,547	3,495,908	3,928,079
Software Licenses [Member]	'	'	'	'
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]	'	'	'	'
Revenues (in Dollars)	430,323	847,297	2,333,016	2,525,933
Professional Services [Member]	'	'	'	'
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]	'	'	'	'
Revenues (in Dollars)	552,719	213,187	1,625,600	638,302
Hosting [Member]	'	'	'	'
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]	'	'	'	'
Revenues (in Dollars)	$199,696	$183,568	$572,935	$517,239

Note_2_Summary_of_Significant_4

Note 2 - Summary of Significant Accounting Policies (Details) - Allowance For Doubtful Account Summary (USD $)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Allowance For Doubtful Account Summary [Abstract]	'	'	'	'	'
Beginning of period	'	'	$84,210	$142,444	$142,444
Bad debt expense	8,191	42,619	-4,830	126,763	-58,234
Write-offs	'	'	-30,000	'	0
End of period	$49,380	'	$49,380	'	$84,210

Note_2_Summary_of_Significant_5

Note 2 - Summary of Significant Accounting Policies (Details) - Customer Concentration	9 Months Ended		12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Sales Revenue, Goods, Net [Member]	'	'	'
Concentration Risk [Line Items]	'	'	'
Number of Customers	1	2	2
Concentration Risk Percentage	11.00%	38.00%	35.00%
Accounts Receivable [Member]	'	'	'
Concentration Risk [Line Items]	'	'	'
Number of Customers	2	1	3
Concentration Risk Percentage	29.00%	13.00%	54.00%

Note_2_Summary_of_Significant_6

Note 2 - Summary of Significant Accounting Policies (Details) - Revenue From European Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Note 2 - Summary of Significant Accounting Policies (Details) - Revenue From European Operations [Line Items]	'	'	'	'
(in Dollars)	$3,477,621	$4,058,320	$10,956,144	$11,897,488
European [Member]	'	'	'	'
Note 2 - Summary of Significant Accounting Policies (Details) - Revenue From European Operations [Line Items]	'	'	'	'
(in Dollars)	'	'	$1,214,121	$1,157,462
	'	'	11.00%	10.00%

Note_4_Earnings_Loss_Per_Share2

Note 4 - Earnings (Loss) Per Share (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Note 4 - Earnings (Loss) Per Share (Details) [Line Items]	'	'	'	'
Weighted Average Number of Shares Outstanding, Basic	87,867,268	86,526,332	87,515,641	86,496,550
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	'	'	79,502,620	82,521,509
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit (in Dollars per share)	'	'	$0.05	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit (in Dollars per share)	'	'	$0.69	'
Minimum [Member]	'	'	'	'
Note 4 - Earnings (Loss) Per Share (Details) [Line Items]	'	'	'	'
Investment Warrants, Exercise Price (in Dollars per share)	'	'	$0.25	'
Debt Instrument, Convertible, Conversion Price (in Dollars per share)	0.25	'	$0.25	'
Maximum [Member]	'	'	'	'
Note 4 - Earnings (Loss) Per Share (Details) [Line Items]	'	'	'	'
Investment Warrants, Exercise Price (in Dollars per share)	'	'	$0.60	'
Debt Instrument, Convertible, Conversion Price (in Dollars per share)	0.5	'	$0.50	'

Note_4_Earnings_Loss_Per_Share3

Note 4 - Earnings (Loss) Per Share (Details) - Reconciliation of Anti-Dilutive Securities	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Anti-Dilutive Security	79,502,620	82,521,509
Shares Of Preferred Stock [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Anti-Dilutive Security	2,750,149	2,750,149
Equity Option [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Anti-Dilutive Security	6,175,000	10,502,500
Warrant [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Anti-Dilutive Security	44,728,873	44,089,580
Convertible Debt Securities [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Anti-Dilutive Security	24,620,000	24,620,000
Shares Issuable For Accrued Interest [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Anti-Dilutive Security	1,228,598	559,280

Note_4_Earnings_Loss_Per_Share4

Note 4 - Earnings (Loss) Per Share (Details) - Computation of Diluted Earnings Per Share (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Computation of Diluted Earnings Per Share [Abstract]	'	'	'	'
(in Dollars)	$1,680,481	($4,465,210)	($4,621,397)	($6,417,743)
	87,867,268	86,526,332	87,515,641	86,496,550
(in Dollars per share)	$0.02	($0.05)	($0.05)	($0.07)
(in Dollars)	0	0	0	0
	0	0	0	0
(in Dollars per share)	$0	$0	$0	$0
(in Dollars)	$1,680,481	($4,465,210)	($4,621,397)	($6,417,743)
	87,867,268	86,526,332	87,515,641	86,496,550
(in Dollars per share)	$0.02	($0.05)	($0.05)	($0.07)

Note_5_Property_and_Equipment_2

Note 5 - Property and Equipment, Net (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Property, Plant and Equipment [Abstract]	'	'	'	'
Depreciation	$54,894	$75,912	$174,436	$308,666

Note_5_Property_and_Equipment_3

Note 5 - Property and Equipment, Net (Details) - Property And Equipment (USD $)	9 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]	'	'
Cost	$3,334,459	$3,225,607
Accumulated Depreciation	2,919,248	2,743,804
Net Book Value	415,211	481,803
Computer And Office Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Cost	1,578,095	1,519,617
Accumulated Depreciation	1,288,626	1,181,451
Net Book Value	289,469	338,166
Estimated Useful Lives	'5 years	'
Leasehold Improvements [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Cost	92,786	92,686
Accumulated Depreciation	73,771	68,044
Net Book Value	19,015	24,642
Estimated Useful Lives	'5 years	'
Software and Software Development Costs [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Cost	1,549,577	1,502,524
Accumulated Depreciation	1,459,622	1,403,705
Net Book Value	89,955	98,819
Estimated Useful Lives	'3 years	'
Furniture and Fixtures [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Cost	114,001	110,780
Accumulated Depreciation	97,229	90,604
Net Book Value	$16,772	$20,176
Estimated Useful Lives	'5 years	'

Note_6_Intangible_Assets_At_Co2

Note 6 - Intangible Assets, At Cost (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Disclosure Text Block [Abstract]	'	'	'	'
Amortization of Intangible Assets	$0	$0	$0	$232,117

Note_6_Intangible_Assets_At_Co3

Note 6 - Intangible Assets, At Cost (Details) - Intangible Assets (USD $)	9 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]	'	'
Cost	$1,392,701	$1,392,701
Accumulated Amortization	1,392,701	1,392,701
Net Book value	0	0
Customer Lists [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Cost	1,392,701	1,392,701
Accumulated Amortization	1,392,701	1,392,701
Net Book value	$0	$0
Estimated Useful Lives	'3 years	'

Note_7_Accounts_Payable_and_Ac2

Note 7 - Accounts Payable and Accrued Expenses (Details) - Accounts Payable And Accrued Expenses (USD $)	Sep. 30, 2013	Dec. 31, 2012
Accounts Payable And Accrued Expenses [Abstract]	'	'
Accounts payable	$356,470	$665,139
Accrued payroll and related costs	466,420	383,859
Other accrued expenses	85,094	124,154
Accrued interest	1,098,196	951,213
Total accounts payable and accrued expenses	$2,006,180	$2,124,365

Note_8_Lines_of_Credit_and_Not2

Note 8 - Lines of Credit and Notes Payable (Details) (USD $)	Sep. 30, 2013	Mar. 18, 2013	Dec. 31, 2012	Jan. 02, 2013	Jan. 02, 2013	Jan. 02, 2013	Feb. 01, 2013	Mar. 05, 2013	Apr. 02, 2013
				Promissory Note 1 [Member]	Promissory Note 2 [Member]	Promissory Note 3 [Member]	Promissory Note 4 [Member]	Promissory Note 5 [Member]	Promissory Note 6 [Member]
Note 8 - Lines of Credit and Notes Payable (Details) [Line Items]	'	'	'	'	'	'	'	'	'
Line of Credit Facility, Maximum Borrowing Capacity	'	$2,000,000	'	'	'	'	'	'	'
Line of Credit Facility, Amount Outstanding	800,000	'	'	'	'	'	'	'	'
Line of Credit Facility, Interest Rate at Period End	2.75%	'	'	'	'	'	'	'	'
Unsecured Debt	5,667,866	'	5,138,866	'	'	'	'	'	'
Debt Instrument, Face Amount	'	'	'	529,000	431,987	45,000	20,000	137,500	2,866,879
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)	'	'	'	2,116,000	'	'	'	'	'
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)	'	'	'	0.25	'	'	'	'	'
Debt Instrument, Interest Rate, Stated Percentage	'	'	'	12.00%	10.00%	12.00%	12.00%	12.00%	12.00%
Derivative Liability	'	'	'	400,142	'	'	'	'	'
Notes Payable	$5,667,866	'	$5,138,866	$128,858	'	'	'	'	'
Debt Instrument, Convertible, Remaining Discount Amortization Period	'	'	'	'36 months	'	'	'	'	'

Note_8_Lines_of_Credit_and_Not3

Note 8 - Lines of Credit and Notes Payable (Details) - Notes Payable (USD $)

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Non-Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Related Party [Member]

Note Payable 10 [Member]

Note Payable 11 [Member]

Note Payable 12 [Member]

Note Payable 13 [Member]

Note Payable 14 [Member]

Note Payable 15 [Member]

Note Payable 16 [Member]

Note Payable 17 [Member]

Note Payable 18 [Member]

Note Payable 19 [Member]

Note Payable 1 [Member]

Note Payable 2 [Member]

Note Payable 3 [Member]

Note Payable 4 [Member]

Note Payable 5 [Member]

Note Payable 6 [Member]

Note Payable 7 [Member]

Note Payable 8 [Member]

Note Payable 9 [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Current [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Long Term [Member]

Note Payable 10 [Member]

Note Payable 11 [Member]

Note Payable 12 [Member]

Note Payable 13 [Member]

Note Payable 14 [Member]

Note Payable 15 [Member]

Note Payable 16 [Member]

Note Payable 17 [Member]

Note Payable 18 [Member]

Note Payable 19 [Member]

Note Payable 1 [Member]

Note Payable 2 [Member]

Note Payable 3 [Member]

Note Payable 4 [Member]

Note Payable 5 [Member]

Note Payable 6 [Member]

Note Payable 7 [Member]

Note Payable 8 [Member]

Note Payable 9 [Member]

Note Payable 10 [Member]

Note Payable 11 [Member]

Note Payable 12 [Member]

Note Payable 13 [Member]

Note Payable 14 [Member]

Note Payable 15 [Member]

Note Payable 16 [Member]

Note Payable 17 [Member]

Note Payable 18 [Member]

Note Payable 19 [Member]

Note Payable 1 [Member]

Note Payable 2 [Member]

Note Payable 3 [Member]

Note Payable 4 [Member]

Note Payable 5 [Member]

Note Payable 6 [Member]

Note Payable 7 [Member]

Note Payable 8 [Member]

Note Payable 9 [Member]

Note Payable 10 [Member]

Note Payable 11 [Member]

Note Payable 12 [Member]

Note Payable 13 [Member]

Note Payable 14 [Member]

Note Payable 15 [Member]

Note Payable 16 [Member]

Note Payable 17 [Member]

Note Payable 18 [Member]

Note Payable 19 [Member]

Note Payable 1 [Member]

Note Payable 2 [Member]

Note Payable 3 [Member]

Note Payable 4 [Member]

Note Payable 5 [Member]

Note Payable 6 [Member]

Note Payable 7 [Member]

Note Payable 8 [Member]

Note Payable 9 [Member]

Note Payable 10 [Member]

Note Payable 11 [Member]

Note Payable 12 [Member]

Note Payable 13 [Member]

Note Payable 14 [Member]

Note Payable 15 [Member]

Note Payable 16 [Member]

Note Payable 17 [Member]

Note Payable 18 [Member]

Note Payable 19 [Member]

Note Payable 1 [Member]

Note Payable 2 [Member]

Note Payable 3 [Member]

Note Payable 4 [Member]

Note Payable 5 [Member]

Note Payable 6 [Member]

Note Payable 7 [Member]

Note Payable 8 [Member]

Note Payable 9 [Member]

Note 8 - Lines of Credit and Notes Payable (Details) - Notes Payable [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maturity date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1-Jan-15

1-Jan-14

16-Dec-14

1-Jan-16

1-Jan-15

1-Jan-15

1-Jan-15

1-Jan-16

1-Jan-15

31-Mar-16

1-Jan-15

1-Jan-15

1-Jan-15

1-Apr-14

1-Jan-15

1-Jan-16

1-Jan-14

1-Jan-15

16-Dec-14

Interest rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

12.00%

12.00%

12.00%

12.00%

10.00%

10.00%

12.00%

12.00%

12.00%

12.00%

10.00%

10.00%

12.00%

12.00%

12.00%

12.00%

12.00%

12.00%

12.00%

Ending principal

$5,667,866

$5,138,866

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1,600,000

$17,500

$20,000

$529,000

$308,562

$123,425

$45,000

$20,000

$137,500

$2,866,879

$308,562

$123,425

$137,500

$2,866,879

$1,600,000

$20,000

$17,500

$45,000

$20,000

Non related party current

17,500

0

0

17,500

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

17,500

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Non related party long term

634,487

651,987

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

20,000

0

308,562

123,425

45,000

0

137,500

0

308,562

123,425

137,500

0

0

0

17,500

45,000

20,000

634,487

651,987

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Related party current

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Related party long term

4,415,963

3,830,355

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,600,000

0

0

529,000

0

0

0

20,000

0

2,866,879

0

0

0

2,866,879

1,600,000

20,000

0

0

0

4,415,963

3,830,355

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Non related party current

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

599,916

656,524

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Non related party long term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

599,916

656,524

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Related party current

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

599,916

656,524

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Related party long term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-599,916

-656,524

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Related party current

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Related party long term

$4,415,963

$3,830,355

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1,600,000

$0

$0

$529,000

$0

$0

$0

$20,000

$0

$2,866,879

$0

$0

$0

$2,866,879

$1,600,000

$20,000

$0

$0

$0

$4,415,963

$3,830,355

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Note_9_Convertible_Notes_Payab2

Note 9 - Convertible Notes Payable (Details) (USD $)

9 Months Ended

0 Months Ended

9 Months Ended

12 Months Ended

1 Months Ended

Sep. 30, 2013

Sep. 30, 2012

Feb. 22, 2013

Jun. 30, 2011

Feb. 27, 2013

Feb. 22, 2013

Mar. 30, 2011

Feb. 22, 2013

Sep. 30, 2009

Mar. 12, 2013

Mar. 06, 2013

Feb. 22, 2013

Sep. 30, 2009

Feb. 22, 2013

Jun. 30, 2011

Feb. 22, 2013

Mar. 30, 2011

Feb. 22, 2013

Feb. 22, 2013

Sep. 30, 2009

Feb. 22, 2013

Dec. 16, 2008

Aug. 29, 2008

Feb. 22, 2013

Mar. 31, 2011

Sep. 30, 2009

Jun. 30, 2008

Feb. 29, 2008

Feb. 22, 2013

Feb. 22, 2013

Feb. 22, 2013

Feb. 22, 2013

Sep. 30, 2013

Dec. 31, 1999

Jun. 30, 2004

Mar. 30, 2011

Sep. 30, 2009

Aug. 29, 2008

Dec. 16, 2008

Dec. 31, 2009

Extended Maturity [Member]

Extended Maturity [Member]

Extended Maturity [Member]

Extended Maturity [Member]

Extended Maturity [Member]

Extended Maturity [Member]

Extended Maturity [Member]

Extended Maturity [Member]

Extended Maturity [Member]

Extended Maturity [Member]

Extended Maturity [Member]

Extended Maturity [Member]

Extended Maturity [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Operating Officer [Member]

Chief Operating Officer [Member]

Chief Technology Officer [Member]

Chief Technology Officer [Member]

Convertible Notes 10% [Member]

Convertible Notes 10% [Member]

Convertible Notes 10% [Member]

Secured Convertible Debentures [Member]

Secured Convertible Debentures [Member]

Convertible Debentures [Member]

Convertible Debentures 2 [Member]

Convertible Debentures 3 [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Former Director Matthew Veateh [Member]

Secured Convertible Debentures [Member]

Secured Convertible Debentures [Member]

Convertible Debentures [Member]

Convertible Debentures [Member]

Convertible Debentures 2 [Member]

Convertible Debentures 2 [Member]

Convertible Debentures 2 [Member]

Convertible Debentures 2 [Member]

Convertible Debentures 3 [Member]

Convertible Debentures 3 [Member]

Secured Convertible Debentures [Member]

Secured Convertible Debentures [Member]

Convertible Debentures [Member]

Convertible Debentures 2 [Member]

Convertible Debentures 2 [Member]

Convertible Debentures 3 [Member]

Convertible Debentures [Member]

Convertible Debentures 2 [Member]

Convertible Debentures [Member]

Convertible Debentures 2 [Member]

Convertible Debentures 3 [Member]

Convertible Debentures 3 [Member]

Convertible Debentures 2 [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10.00%

'

12.00%

'

'

'

'

'

'

'

'

10.00%

'

'

12.00%

10.00%

12.00%

12.00%

Convertible Notes Payable

'

'

$1,440,000

$1,440,000

$15,000

$1,200,000

$1,200,000

$150,000

$1,920,000

$100,000

$200,000

$4,505,000

$4,980,000

$1,490,000

$1,490,000

$1,100,000

$1,100,000

$1,770,000

$4,475,000

$4,350,000

$4,475,000

'

$1,260,000

$1,770,000

'

$1,770,000

$510,000

$4,200,000

$25,000

$25,000

$5,000

$5,000

'

$862,500

'

'

$1,400,000

$2,270,000

$5,075,000

$1,490,000

Debt Issuance Cost

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

119,625

'

'

'

'

'

'

Proceeds from Issuance of Debt (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

742,875

'

'

'

'

'

'

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.50

$0.50

'

'

'

'

'

'

'

'

'

'

'

$1.25

'

$0.25

$0.50

$0.50

$0.25

Debt Conversion, Converted Instrument, Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,350,000

510,000

'

'

'

'

'

'

'

'

'

787,500

'

'

'

'

'

'

'

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,495,179

'

'

'

'

'

'

'

Long-term Debt, Gross

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

75,000

'

'

'

'

'

'

'

Interest Payable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

107,858

'

'

'

'

'

'

'

Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8,700,000

3,540,000

'

11,467,517

'

'

'

'

'

'

'

'

'

'

'

5,600,000

4,540,000

10,150,000

5,960,000

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.25

'

'

'

'

'

'

'

'

'

'

'

0.25

'

'

0.25

Repayments of Notes Payable

$0

$131,800

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$200,000

'

'

'

'

Note_9_Convertible_Notes_Payab3

Note 9 - Convertible Notes Payable (Details) - Convertible Debt (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	$275,000	$75,000
Convertible Debt, Nonrelated Parties, Current	275,000	75,000
Convertible Debt, Related Parties, Long Term	265,000	465,000
Convertible Debt, Nonrelated Parties, Long Term	265,000	465,000
Principal Outstanding [Member] | Convertible Notes Payable 10% $862,500 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Principal	75,000	75,000
Convertible Debt, Carrying amount	75,000	75,000
Principal Outstanding [Member] | Convertible Notes Payable 10% $150,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Principal	150,000	150,000
Convertible Debt, Carrying amount	150,000	150,000
Principal Outstanding [Member] | Convertible Notes Payable 10% $2,120,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Principal	1,770,000	1,770,000
Convertible Debt, Carrying amount	1,770,000	1,770,000
Principal Outstanding [Member] | Convertible Notes Payable 12% $160,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Principal	160,000	160,000
Convertible Debt, Carrying amount	160,000	160,000
Principal Outstanding [Member] | Convertible Notes Payable 12% $200,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Principal	200,000	200,000
Convertible Debt, Carrying amount	200,000	200,000
Principal Outstanding [Member] | Convertible Notes Payable 12% $100,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Principal	100,000	100,000
Convertible Debt, Carrying amount	100,000	100,000
Principal Outstanding [Member] | Convertible Notes Payable 12% $4,615,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Principal	4,520,000	4,520,000
Convertible Debt, Carrying amount	4,520,000	4,520,000
Principal Outstanding [Member] | Convertible Notes Payable 12% $1,400,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Principal	1,200,000	1,200,000
Convertible Debt, Carrying amount	1,200,000	1,200,000
Principal Outstanding [Member] | Convertible Notes Payable 12% $1,490,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Principal	1,490,000	1,490,000
Convertible Debt, Carrying amount	1,490,000	1,490,000
Principal Outstanding [Member] | Total [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Principal	9,665,000	9,665,000
Convertible Debt, Carrying amount	9,665,000	9,665,000
Allocated Discount [Member] | Convertible Notes Payable 10% $862,500 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Allocated discount	0	0
Allocated Discount [Member] | Convertible Notes Payable 10% $150,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Allocated discount	135,600	135,600
Allocated Discount [Member] | Convertible Notes Payable 10% $2,120,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Allocated discount	1,916,480	1,916,480
Allocated Discount [Member] | Convertible Notes Payable 12% $160,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Allocated discount	44,024	44,024
Allocated Discount [Member] | Convertible Notes Payable 12% $200,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Allocated discount	55,030	55,030
Allocated Discount [Member] | Convertible Notes Payable 12% $100,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Allocated discount	27,515	27,515
Allocated Discount [Member] | Convertible Notes Payable 12% $4,615,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Allocated discount	1,243,681	1,243,681
Allocated Discount [Member] | Convertible Notes Payable 12% $1,400,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Allocated discount	526,400	526,400
Allocated Discount [Member] | Convertible Notes Payable 12% $1,490,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Allocated discount	935,720	935,720
Allocated Discount [Member] | Total [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Allocated discount	4,884,450	4,884,450
Related Parties [Member] | Convertible Notes Payable 10% $862,500 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	0	0
Convertible Debt, Nonrelated Parties, Current	0	0
Convertible Debt, Related Parties, Long Term	0	0
Convertible Debt, Nonrelated Parties, Long Term	0	0
Related Parties [Member] | Convertible Notes Payable 10% $150,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	0	0
Convertible Debt, Nonrelated Parties, Current	0	0
Convertible Debt, Related Parties, Long Term	150,000	150,000
Convertible Debt, Nonrelated Parties, Long Term	150,000	150,000
Related Parties [Member] | Convertible Notes Payable 10% $2,120,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	0	0
Convertible Debt, Nonrelated Parties, Current	0	0
Convertible Debt, Related Parties, Long Term	1,770,000	1,770,000
Convertible Debt, Nonrelated Parties, Long Term	1,770,000	1,770,000
Related Parties [Member] | Convertible Notes Payable 12% $160,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	160,000	160,000
Convertible Debt, Nonrelated Parties, Current	160,000	160,000
Convertible Debt, Related Parties, Long Term	0	0
Convertible Debt, Nonrelated Parties, Long Term	0	0
Related Parties [Member] | Convertible Notes Payable 12% $200,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	0	0
Convertible Debt, Nonrelated Parties, Current	0	0
Convertible Debt, Related Parties, Long Term	0	0
Convertible Debt, Nonrelated Parties, Long Term	0	0
Related Parties [Member] | Convertible Notes Payable 12% $100,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	0	0
Convertible Debt, Nonrelated Parties, Current	0	0
Convertible Debt, Related Parties, Long Term	0	0
Convertible Debt, Nonrelated Parties, Long Term	0	0
Related Parties [Member] | Convertible Notes Payable 12% $4,615,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	0	0
Convertible Debt, Nonrelated Parties, Current	0	0
Convertible Debt, Related Parties, Long Term	4,505,000	4,505,000
Convertible Debt, Nonrelated Parties, Long Term	4,505,000	4,505,000
Related Parties [Member] | Convertible Notes Payable 12% $1,400,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	0	0
Convertible Debt, Nonrelated Parties, Current	0	0
Convertible Debt, Related Parties, Long Term	1,100,000	1,100,000
Convertible Debt, Nonrelated Parties, Long Term	1,100,000	1,100,000
Related Parties [Member] | Convertible Notes Payable 12% $1,490,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	0	0
Convertible Debt, Nonrelated Parties, Current	0	0
Convertible Debt, Related Parties, Long Term	1,440,000	1,440,000
Convertible Debt, Nonrelated Parties, Long Term	1,440,000	1,440,000
Related Parties [Member] | Total [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	160,000	160,000
Convertible Debt, Nonrelated Parties, Current	160,000	160,000
Convertible Debt, Related Parties, Long Term	8,965,000	8,965,000
Convertible Debt, Nonrelated Parties, Long Term	8,965,000	8,965,000
Nonrelated Parties [Member] | Convertible Notes Payable 10% $862,500 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	75,000	75,000
Convertible Debt, Nonrelated Parties, Current	75,000	75,000
Convertible Debt, Related Parties, Long Term	0	0
Convertible Debt, Nonrelated Parties, Long Term	0	0
Nonrelated Parties [Member] | Convertible Notes Payable 10% $150,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	0	0
Convertible Debt, Nonrelated Parties, Current	0	0
Convertible Debt, Related Parties, Long Term	0	0
Convertible Debt, Nonrelated Parties, Long Term	0	0
Nonrelated Parties [Member] | Convertible Notes Payable 10% $2,120,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	0	0
Convertible Debt, Nonrelated Parties, Current	0	0
Convertible Debt, Related Parties, Long Term	0	0
Convertible Debt, Nonrelated Parties, Long Term	0	0
Nonrelated Parties [Member] | Convertible Notes Payable 12% $160,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	0	0
Convertible Debt, Nonrelated Parties, Current	0	0
Convertible Debt, Related Parties, Long Term	0	0
Convertible Debt, Nonrelated Parties, Long Term	0	0
Nonrelated Parties [Member] | Convertible Notes Payable 12% $200,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	200,000	0
Convertible Debt, Nonrelated Parties, Current	200,000	0
Convertible Debt, Related Parties, Long Term	0	200,000
Convertible Debt, Nonrelated Parties, Long Term	0	200,000
Nonrelated Parties [Member] | Convertible Notes Payable 12% $100,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	0	0
Convertible Debt, Nonrelated Parties, Current	0	0
Convertible Debt, Related Parties, Long Term	100,000	100,000
Convertible Debt, Nonrelated Parties, Long Term	100,000	100,000
Nonrelated Parties [Member] | Convertible Notes Payable 12% $4,615,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	0	0
Convertible Debt, Nonrelated Parties, Current	0	0
Convertible Debt, Related Parties, Long Term	15,000	15,000
Convertible Debt, Nonrelated Parties, Long Term	15,000	15,000
Nonrelated Parties [Member] | Convertible Notes Payable 12% $1,400,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	0	0
Convertible Debt, Nonrelated Parties, Current	0	0
Convertible Debt, Related Parties, Long Term	100,000	100,000
Convertible Debt, Nonrelated Parties, Long Term	100,000	100,000
Nonrelated Parties [Member] | Convertible Notes Payable 12% $1,490,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	0	0
Convertible Debt, Nonrelated Parties, Current	0	0
Convertible Debt, Related Parties, Long Term	50,000	50,000
Convertible Debt, Nonrelated Parties, Long Term	50,000	50,000
Nonrelated Parties [Member] | Total [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Related Parties, Current	275,000	75,000
Convertible Debt, Nonrelated Parties, Current	275,000	75,000
Convertible Debt, Related Parties, Long Term	265,000	465,000
Convertible Debt, Nonrelated Parties, Long Term	265,000	465,000
Convertible Notes Payable 10% $862,500 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Maturity date	30-Jun-04	30-Jun-04
Convertible Debt, Interest rate	10.00%	10.00%
Convertible Debt, Original principal	862,500	862,500
Convertible Debt, Principal	75,000	75,000
Convertible Debt, Total discount amortized	0	0
Convertible Debt, Discount	0	0
Convertible Debt, Carrying amount	75,000	75,000
Convertible Notes Payable 10% $150,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Maturity date	1-Jan-15	1-Jan-15
Convertible Debt, Interest rate	10.00%	10.00%
Convertible Debt, Original principal	150,000	150,000
Convertible Debt, Principal	150,000	150,000
Convertible Debt, Total discount amortized	135,600	135,600
Convertible Debt, Discount	0	0
Convertible Debt, Carrying amount	150,000	150,000
Convertible Notes Payable 10% $2,120,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Maturity date	1-Jan-16	1-Jan-16
Convertible Debt, Interest rate	10.00%	10.00%
Convertible Debt, Original principal	2,120,000	2,120,000
Convertible Debt, Principal	1,770,000	1,770,000
Convertible Debt, Total discount amortized	1,916,480	1,916,480
Convertible Debt, Discount	0	0
Convertible Debt, Carrying amount	1,770,000	1,770,000
Convertible Notes Payable 12% $160,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Maturity date	16-Dec-13	16-Dec-13
Convertible Debt, Interest rate	12.00%	12.00%
Convertible Debt, Original principal	160,000	160,000
Convertible Debt, Principal	160,000	160,000
Convertible Debt, Total discount amortized	44,024	44,024
Convertible Debt, Discount	0	0
Convertible Debt, Carrying amount	160,000	160,000
Convertible Notes Payable 12% $200,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Maturity date	1-Jan-14	1-Jan-14
Convertible Debt, Interest rate	12.00%	12.00%
Convertible Debt, Original principal	200,000	200,000
Convertible Debt, Principal	200,000	200,000
Convertible Debt, Total discount amortized	55,030	55,030
Convertible Debt, Discount	0	0
Convertible Debt, Carrying amount	200,000	200,000
Convertible Notes Payable 12% $100,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Maturity date	1-Jan-15	1-Jan-15
Convertible Debt, Interest rate	12.00%	12.00%
Convertible Debt, Original principal	100,000	100,000
Convertible Debt, Principal	100,000	100,000
Convertible Debt, Total discount amortized	27,515	27,515
Convertible Debt, Discount	0	0
Convertible Debt, Carrying amount	100,000	100,000
Convertible Notes Payable 12% $4,615,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Maturity date	1-Jan-16	1-Jan-16
Convertible Debt, Interest rate	12.00%	12.00%
Convertible Debt, Original principal	4,615,000	4,615,000
Convertible Debt, Principal	4,520,000	4,520,000
Convertible Debt, Total discount amortized	1,243,681	1,243,681
Convertible Debt, Discount	0	0
Convertible Debt, Carrying amount	4,520,000	4,520,000
Convertible Notes Payable 12% $1,400,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Maturity date	1-Jan-16	1-Jan-16
Convertible Debt, Interest rate	12.00%	12.00%
Convertible Debt, Original principal	1,400,000	1,400,000
Convertible Debt, Principal	1,200,000	1,200,000
Convertible Debt, Total discount amortized	526,400	526,400
Convertible Debt, Discount	0	0
Convertible Debt, Carrying amount	1,200,000	1,200,000
Convertible Notes Payable 12% $1,490,000 [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Maturity date	1-Jan-16	1-Jan-16
Convertible Debt, Interest rate	12.00%	12.00%
Convertible Debt, Original principal	1,490,000	1,490,000
Convertible Debt, Principal	1,490,000	1,490,000
Convertible Debt, Total discount amortized	935,720	935,720
Convertible Debt, Discount	0	0
Convertible Debt, Carrying amount	1,490,000	1,490,000
Total [Member]	'	'
Debt Instrument [Line Items]	'	'
Convertible Debt, Original principal	11,097,500	11,097,500
Convertible Debt, Principal	9,665,000	9,665,000
Convertible Debt, Total discount amortized	4,884,450	4,884,450
Convertible Debt, Discount	0	0
Convertible Debt, Carrying amount	$9,665,000	$9,665,000

Note_9_Convertible_Notes_Payab4

Note 9 - Convertible Notes Payable (Details) - Convertible Debt Maturity Payments (Convertible Debt [Member], USD $)	Sep. 30, 2013
Convertible Debt [Member]	'
Note 9 - Convertible Notes Payable (Details) - Convertible Debt Maturity Payments [Line Items]	'
2013	$235,000
2014	200,000
2015	250,000
2016	8,980,000
Total	$9,665,000

Note_10_Fair_Value_Measurement2

Note 10 - Fair Value Measurement (Details) - Fair Value of Liabilities Measured On A Recurring Basis (USD $)	Sep. 30, 2013		Dec. 31, 2012
Derivatives: (1) (2)	'		'
Derivative liability Fair Value	$11,499,734	[1],[2]	$8,574,921	[1],[3]
Conversion Feature Liability [Member] | Fair Value, Inputs, Level 1 [Member]	'		'
Derivatives: (1) (2)	'		'
Derivative liability Fair Value	0	[1],[2]	0	[1],[3]
Conversion Feature Liability [Member] | Fair Value, Inputs, Level 2 [Member]	'		'
Derivatives: (1) (2)	'		'
Derivative liability Fair Value	0	[1],[2]	0	[1],[3]
Conversion Feature Liability [Member] | Fair Value, Inputs, Level 3 [Member]	'		'
Derivatives: (1) (2)	'		'
Derivative liability Fair Value	4,024,558	[1],[2]	2,287,323	[1],[3]
Conversion Feature Liability [Member]	'		'
Derivatives: (1) (2)	'		'
Derivative liability Fair Value	4,024,558	[1],[2]	2,287,323	[1],[3]
Warrant Liability [Member] | Fair Value, Inputs, Level 1 [Member]	'		'
Derivatives: (1) (2)	'		'
Derivative liability Fair Value	0	[1],[2]	0	[1],[3]
Warrant Liability [Member] | Fair Value, Inputs, Level 2 [Member]	'		'
Derivatives: (1) (2)	'		'
Derivative liability Fair Value	0	[1],[2]	0	[1],[3]
Warrant Liability [Member] | Fair Value, Inputs, Level 3 [Member]	'		'
Derivatives: (1) (2)	'		'
Derivative liability Fair Value	7,475,176	[1],[2]	6,287,598	[1],[3]
Warrant Liability [Member]	'		'
Derivatives: (1) (2)	'		'
Derivative liability Fair Value	7,475,176	[1],[2]	6,287,598	[1],[3]
Fair Value, Inputs, Level 1 [Member]	'		'
Derivatives: (1) (2)	'		'
Derivative liability Fair Value	0	[1],[2]	0	[1],[3]
Fair Value, Inputs, Level 2 [Member]	'		'
Derivatives: (1) (2)	'		'
Derivative liability Fair Value	0	[1],[2]	0	[1],[3]
Fair Value, Inputs, Level 3 [Member]	'		'
Derivatives: (1) (2)	'		'
Derivative liability Fair Value	$11,499,734	[1],[2]	$8,574,921	[1],[3]
[1]	The fair value at the measurement date is equal to their carrying value on the balance sheet
[2]	The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with the following assumptions for the nine months ended September 30, 2013
[3]	The fair value of the derivative instruments was estimated using the Black Scholes option pricing model with the following assumptions for the year ended December 31, 2012

Note_10_Fair_Value_Measurement3

Note 10 - Fair Value Measurement (Details) - Fair Value Assumptions	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Risk free interest rate	0.13%	'
Dividend yield	0.00%	0.00%
Conversion Feature Liability [Member] | Minimum [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Expected life	'76 days	'3 months
Conversion Feature Liability [Member] | Maximum [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Expected life	'2 years 3 months	'350 days
Warrant Liability [Member] | Minimum [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Expected life	'76 days	'240 days
Warrant Liability [Member] | Maximum [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Expected life	'2 years 6 months	'3 years 3 months
Minimum [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Risk free interest rate	'	0.18%
Expected volatility	191.87%	218.20%
Maximum [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Risk free interest rate	'	0.36%
Expected volatility	235.24%	259.10%

Note_10_Fair_Value_Measurement4

Note 10 - Fair Value Measurement (Details) - Unrealized Gain or Loss Inclued in Earnings (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Unrealized Gain or Loss Inclued in Earnings [Abstract]	'	'
The net amount of (losses) for the period included in earnings attributable to the unrealized loss from changes in derivative liabilities at the reporting date	($2,524,671)	($4,804,260)
Total unrealized (losses) included in earnings	($2,524,671)	($4,804,260)

Note_10_Fair_Value_Measurement5

Note 10 - Fair Value Measurement (Details) - Level 3 Financial Assets And Financial Liabilities At Fair Value (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Derivatives:	'	'
Balance, Beginning of year	$8,574,921	$2,451,619
Net realized gains/(losses)	0	0
Net unrealized (gains)/losses relating to instruments still held at the reporting date	2,524,671	6,123,302
Net purchases, issuances and settlements	400,142	0
Net transfers In and/or out of level 3	0	0
Balance, end of period	11,499,734	8,574,921
Conversion Feature Liability [Member]	'	'
Derivatives:	'	'
Balance, Beginning of year	2,287,323	758,911
Net realized gains/(losses)	0	0
Net unrealized (gains)/losses relating to instruments still held at the reporting date	1,737,235	1,528,412
Net purchases, issuances and settlements	0	0
Net transfers In and/or out of level 3	0	0
Balance, end of period	4,024,558	2,287,323
Warrant Liability [Member]	'	'
Derivatives:	'	'
Balance, Beginning of year	6,287,598	1,692,708
Net realized gains/(losses)	0	0
Net unrealized (gains)/losses relating to instruments still held at the reporting date	787,436	4,594,890
Net purchases, issuances and settlements	400,142	0
Net transfers In and/or out of level 3	0	0
Balance, end of period	$7,475,176	$6,287,598

Note_11_Commitments_and_Contin2

Note 11 - Commitments and Contingencies (Details) (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Commitments and Contingencies Disclosure [Abstract]	'	'
Operating Leases, Rent Expense	$665,932	$649,424
Patent Royalty Percentage Obligation	2.00%	'
Other Expenses	$144,972	$166,442

Note_11_Commitments_and_Contin3

Note 11 - Commitments and Contingencies (Details) - Future Minimum Lease Payments (USD $)	Sep. 30, 2013
Future Minimum Lease Payments [Abstract]	'
2013	$146,166
2014	528,154
2015	493,130
2016	270,852
2017	45,682
Total	$1,483,984

Note_11_Commitments_and_Contin4

Note 11 - Commitments and Contingencies (Details) - Minimum Royalty Payments Per Year (USD $)	Sep. 30, 2013
Minimum Royalty Payments Per Year [Abstract]	'
2013	$625,000
2014	450,000
2015	450,000
2016	450,000
2017	450,000
Total	$2,425,000

Note_12_Related_Party_Transact1

Note 12 - Related Party Transactions (Details) (USD $)

3 Months Ended

9 Months Ended

0 Months Ended

0 Months Ended

0 Months Ended

9 Months Ended

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Mar. 18, 2013

Oct. 16, 2012

Dec. 31, 2011

Feb. 01, 2013

Feb. 22, 2013

Feb. 22, 2013

Feb. 22, 2013

Feb. 22, 2013

Feb. 22, 2013

Feb. 22, 2013

Feb. 22, 2013

Sep. 30, 2009

Feb. 22, 2013

Sep. 30, 2009

Dec. 31, 2009

Mar. 31, 2011

Mar. 31, 2011

Mar. 31, 2011

Mar. 31, 2011

Mar. 31, 2011

Dec. 31, 2011

Dec. 31, 2011

Dec. 31, 2011

Dec. 31, 2011

Dec. 31, 2011

Dec. 31, 2011

Dec. 16, 2008

Aug. 29, 2008

Sep. 30, 2013

Mar. 18, 2013

Feb. 22, 2013

Mar. 31, 2011

Sep. 30, 2009

Jun. 30, 2008

Feb. 29, 2008

Jan. 02, 2013

Dec. 31, 2011

Sep. 30, 2013

Sep. 30, 2012

Aug. 29, 2008

Dec. 16, 2008

Dec. 31, 2009

Purchased From Chief Financial Officer [Member]

Accrued and Unpaid Interest [Member]

Chief Technology Officer [Member]

Chief Technology Officer [Member]

Chief Technology Officer [Member]

Director [Member]

Chief Operating Officer [Member]

Chief Operating Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

CEO and Director Cornelis F. Wit [Member]

CEO and Director Cornelis F. Wit [Member]

Excluding Interest Expense From Derivatives [Member]

Excluding Interest Expense From Derivatives [Member]

Convertible Debentures [Member]

Convertible Debentures 2 [Member]

Convertible Debentures 3 [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

Promissory Note [Member]

Convertible Debentures [Member]

Convertible Debentures 2 [Member]

Convertible Debentures [Member]

Convertible Debentures [Member]

Convertible Debentures 2 [Member]

Convertible Debentures [Member]

Convertible Debentures 2 [Member]

Convertible Debentures 2 [Member]

Convertible Debentures 3 [Member]

Aggregated September 30, 2009 [Member]

Aggregated December 31, 2009 [Member]

Issued April 13, 2010 [Member]

Issued June 29, 2010 [Member]

Issued September 30, 2010 [Member]

Issued December 31, 2010 [Member]

Issued December 31, 2010 2 [Member]

Issued May 13, 2011 [Member]

Issued September 30, 2011 [Member]

Issued October 5, 2011 [Member]

Issued October 28, 2011 [Member]

Issued October 31, 2011 [Member]

Issued November 23, 2011 [Member]

Note 12 - Related Party Transactions (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Notes Payable, Related Parties

'

'

'

'

'

'

'

$20,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$2,866,879

'

'

$150,000

$529,000

$1,600,000

'

'

'

'

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

'

12.00%

'

'

'

'

'

'

'

'

'

12.00%

12.00%

'

'

'

'

'

'

'

'

'

'

'

'

10.00%

'

'

'

12.00%

'

'

'

12.00%

12.00%

'

'

10.00%

12.00%

12.00%

Convertible Notes Payable

'

'

'

'

'

125,000

'

'

5,000

5,000

150,000

25,000

25,000

1,770,000

4,475,000

4,350,000

4,475,000

1,100,000

1,440,000

'

'

'

'

'

'

'

'

'

'

'

'

1,260,000

'

'

1,770,000

'

1,770,000

510,000

4,200,000

'

'

'

'

2,270,000

5,075,000

1,490,000

Due to Related Parties

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

13,780,879

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Converted Instrument, Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,350,000

510,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)

'

'

'

'

'

250,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8,700,000

3,540,000

'

'

'

11,467,517

'

'

'

2,116,000

6,400,000

'

'

4,540,000

10,150,000

5,960,000

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.50

$0.50

'

'

'

'

'

'

'

'

'

'

'

$0.50

$0.50

$0.25

Debt Conversion, Converted Instrument, Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

12.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Number of Equity Instruments

'

'

24,620,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants and Rights Outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,400,000

5,760,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.25

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.25

'

'

'

0.25

0.25

'

'

'

'

0.25

Debt Conversion, Original Debt, Amount

'

'

'

'

'

'

767,000

'

'

'

'

'

'

'

'

'

'

'

'

450,000

115,000

695,000

1,197,500

409,379

96,000

342,000

130,000

123,000

82,000

60,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Maximum Borrowing Capacity

'

'

'

'

2,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Interest Expense, Related Party

$588,425

$527,442

$1,750,327

$1,573,444

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1,750,327

$1,573,444

'

'

'

Note_13_Stockholders_Deficit_D

Note 13 - Stockholders' (Deficit) (Details) (USD $)	9 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Note 13 - Stockholders' (Deficit) (Details) [Line Items]	'	'
Common Stock, Shares Authorized	250,000,000	250,000,000
Common Stock, Par or Stated Value Per Share (in Dollars per share)	$0.00	$0.00
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)	$0.00	$0.00
Common Stock, Shares, Issued	87,834,659	86,598,659
Common Stock, Shares, Outstanding	87,834,659	86,598,659
Class of Warrant or Right, Outstanding	44,728,873	43,412,873
Preferred Stock, Shares Outstanding	4,125,224	'
Convertible Debt (in Dollars)	$9,665,000	'
Debt Instrument, Convertible, Number of Equity Instruments	24,620,000	'
Series A Preferred Stock [Member]	'	'
Note 13 - Stockholders' (Deficit) (Details) [Line Items]	'	'
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)	$0.00	$0.00
Preferred Stock, Dividend Rate, Percentage	5.00%	'
Preferred Stock, Shares Issued	4,125,224	4,125,224
Preferred Stock, Shares Outstanding	4,125,224	4,125,224
Series B Preferred Stock [Member]	'	'
Note 13 - Stockholders' (Deficit) (Details) [Line Items]	'	'
Preferred Stock, Shares Authorized	230,000	230,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)	$0.00	$0.00
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Series C Preferred Stock [Member]	'	'
Note 13 - Stockholders' (Deficit) (Details) [Line Items]	'	'
Preferred Stock, Shares Authorized	747,500	747,500
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)	$0.00	$0.00
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Series D Preferred Stock [Member]	'	'
Note 13 - Stockholders' (Deficit) (Details) [Line Items]	'	'
Preferred Stock, Shares Authorized	250,000	250,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)	$0.00	$0.00
Preferred Stock, Shares Issued	250,000	250,000
Preferred Stock, Shares Outstanding	250,000	250,000

Note_13_Stockholders_Deficit_D1

Note 13 - Stockholders' (Deficit) (Details) - Cumulative Arrearage of Undeclared Dividends (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Note 13 - Stockholders' (Deficit) (Details) - Cumulative Arrearage of Undeclared Dividends [Line Items]	'	'
Preferred Stock, Dividend, Cumulative arrearage	$4,410,430	$4,204,169
Series A Preferred Stock [Member]	'	'
Note 13 - Stockholders' (Deficit) (Details) - Cumulative Arrearage of Undeclared Dividends [Line Items]	'	'
Preferred Stock, Dividend, Cumulative arrearage	2,328,450	2,122,189
Preferred Stock, Dividend, Cumulative arrearage per share (in Dollars per share)	$0.56	$0.51
Series B Preferred Stock [Member]	'	'
Note 13 - Stockholders' (Deficit) (Details) - Cumulative Arrearage of Undeclared Dividends [Line Items]	'	'
Preferred Stock, Dividend, Cumulative arrearage	609,887	609,887
Preferred Stock, Dividend, Cumulative arrearage per share (in Dollars per share)	$3.05	$3.05
Series C Preferred Stock [Member]	'	'
Note 13 - Stockholders' (Deficit) (Details) - Cumulative Arrearage of Undeclared Dividends [Line Items]	'	'
Preferred Stock, Dividend, Cumulative arrearage	$1,472,093	$1,472,093
Preferred Stock, Dividend, Cumulative arrearage per share (in Dollars per share)	$4.37	$4.37

Note_13_Stockholders_Deficit_D2

Note 13 - Stockholders' (Deficit) (Details) - Dividends Payable (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Series A Preferred Stock [Member]	'	'
Dividends Payable [Line Items]	'	'
Dividends accreted (in Dollars)	$154,272	$177,528
Divideds accreted per share	$0.04	$0.04
Series B Preferred Stock [Member]	'	'
Dividends Payable [Line Items]	'	'
Dividends accreted (in Dollars)	0	0
Divideds accreted per share	$0	$0
Series C Preferred Stock [Member]	'	'
Dividends Payable [Line Items]	'	'
Dividends accreted (in Dollars)	$0	$0
Divideds accreted per share	$0	$0

Note_13_Stockholders_Deficit_D3

Note 13 - Stockholders' (Deficit) (Details) - Warrants (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Class of Warrant or Right [Line Items]	'	'
Number of Warrants Outstanding	44,728,873	43,412,873
Number of Warrants Exercisable	44,728,873	'
Exercise Price Range $0.25 to $0.60 [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Number of Warrants Outstanding	44,728,873	43,412,873
Weighted Average Remaining Contractual Life	'2 years 98 days	'2 years 116 days
Warrants Outstanding, Weighted Average Exercise Price (in Dollars per share)	$0.36	$0.36
Number of Warrants Exercisable	44,728,873	43,412,873
Warrants Exercisable, Weighted Average Exercise Price (in Dollars per share)	$0.36	$0.36
Exercise Price Range $0.25 to $0.60 [Member] | Minimum [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Range of Exercise Price (in Dollars per Item)	0.25	0.25
Exercise Price Range $0.25 to $0.60 [Member] | Maximum [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Range of Exercise Price (in Dollars per Item)	0.6	0.6

Note_13_Stockholders_Deficit_D4

Note 13 - Stockholders' (Deficit) (Details) - Warrants Activity (USD $)	9 Months Ended
	Sep. 30, 2013
Warrants Activity [Abstract]	'
Balance at December 31, 2012	43,412,873
Issued	2,116,000
Exercised	0
Expired/forfeited	-800,000
Balance at September 30, 2013	44,728,873
Warrants exercisable at September 30, 2013	44,728,873
Weighted average fair value of warrants granted during 2013 (in Dollars)	$0.21

Note_13_Stockholders_Deficit_D5

Note 13 - Stockholders' (Deficit) (Details) - Accumulated Other Comprehensive Gain (Loss) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Accumulated Other Comprehensive Gain (Loss) [Abstract]	'	'	'	'	'
Foreign Currency Translation	'	'	($69,092)	($53,714)	($53,714)
Accumulated other comprehensive income (loss)	'	'	-69,092	-53,714	-53,714
Foreign Currency Translation	-3,006	-3,398	-30,485	-10,586	-15,378
Accumulated other comprehensive income (loss)	-3,006	-3,398	-30,485	-10,586	-15,378
Foreign Currency Translation	-99,577	'	-99,577	'	-69,092
Accumulated other comprehensive income (loss)	($99,577)	'	($99,577)	'	($69,092)

Note_14_Employee_Equity_Incent2

Note 14 - Employee Equity Incentive Plans (Details) (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012	Dec. 31, 2011
Note 14 - Employee Equity Incentive Plans (Details) [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	6,175,000	'	10,452,500	11,158,000
Proceeds from Stock Options Exercised (in Dollars)	$0	$0	'	'
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense (in Dollars)	0	0	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)	$0.17	$0.10	'	'
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options (in Dollars)	$68,959	'	'	'
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	'292 days	'	'	'
Restricted Stock [Member] | Equity Incentive Plan 2009 [Member]	'	'	'	'
Note 14 - Employee Equity Incentive Plans (Details) [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number	1,225,000	'	'	'
Equity Incentive Plan 2009 [Member]	'	'	'	'
Note 14 - Employee Equity Incentive Plans (Details) [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	7,500,000	'	'	'
Stock Option Expiration Term	'5 years	'	'	'
Vesting Percentage Year 1	50.00%	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	3,851,000	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	2,424,000	'	'	'
Equity Incentive Plan 2009 [Member] | Maximum [Member]	'	'	'	'
Note 14 - Employee Equity Incentive Plans (Details) [Line Items]	'	'	'	'
Stock Option Grant Term	'10 years	'	'	'
Stock Incentive Plan 1998 [Member]	'	'	'	'
Note 14 - Employee Equity Incentive Plans (Details) [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	12,500,000	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	2,324,000	'	'	'

Note_14_Employee_Equity_Incent3

Note 14 - Employee Equity Incentive Plans (Details) - Stock Option Activity (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012	Dec. 31, 2011
Stock Option Activity [Abstract]	'	'	'
Number of shares	6,175,000	10,452,500	11,158,000
Weighted average exercise price (per share) (in Dollars per share)	$0.30	$0.36	$0.37
Weighted average remaining contractual term (in years)	'1 year 262 days	'1 year 248 days	'2 years 189 days
Aggregate intrinsic value (in Dollars)	$133,165	$149,598	$0
Number of shares	200,000	425,000	'
Weighted average exercise price (per share) (in Dollars per share)	$0.18	$0.12	'
Number of shares	-100,000	-265,000	'
Weighted average exercise price (per share) (in Dollars per share)	$0.18	$0.20	'
Number of shares	-4,377,500	-865,500	'
Weighted average exercise price (per share) (in Dollars per share)	$0.43	$0.43	'
Vested and exercisable at September 30, 2013	5,329,166	'	'
Vested and exercisable at September 30, 2013 (in Dollars per share)	$0.33	'	'
Vested and exercisable at September 30, 2013	'1 year 164 days	'	'
Vested and exercisable at September 30, 2013 (in Dollars)	$82,165	'	'

Note_14_Employee_Equity_Incent4

Note 14 - Employee Equity Incentive Plans (Details) - Vested Shares (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Vested Shares [Abstract]	'	'
Number of options vested	593,833	691,333
Fair value of options vested (in Dollars)	$62,204	$70,383

Note_14_Employee_Equity_Incent5

Note 14 - Employee Equity Incentive Plans (Details) - Stock Options Oustanding (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'
Strike Price Range Lower Limit	$0.05	'
Strike Price Range Upper Limit	$0.69	'
Strike Price Range 0.00 to 0.20 [Member]	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'
Strike Price Range Lower Limit	$0	$0
Strike Price Range Upper Limit	$0.20	$0.20
Outstanding Stock Options (in Shares)	3,111,000	3,428,500
Weighted Average Remaining Contractual Life	'2 years 105 days	'3 years 7 days
Weighted Average Outstanding Strike Price	$0.15	$0.15
Vested Stock Options (in Shares)	2,365,166	2,035,083
Weighted Average Remianing Vested Life	'1 year 354 days	'2 years 6 months
Weighted Average Vested Strike Price	$0.16	$0.17
Strike Price Range 0.21 to 0.29 [Member]	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'
Strike Price Range Lower Limit	$0.21	$0.21
Strike Price Range Upper Limit	$0.29	$0.29
Outstanding Stock Options (in Shares)	1,025,000	2,550,000
Weighted Average Remaining Contractual Life	'1 year 160 days	'1 year 65 days
Weighted Average Outstanding Strike Price	$0.25	$0.26
Vested Stock Options (in Shares)	925,000	2,550,000
Weighted Average Remianing Vested Life	'1 year 29 days	'1 year 65 days
Weighted Average Vested Strike Price	$0.25	$0.26
Strike Price Range 0.30 to 0.49 [Member]	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'
Strike Price Range Lower Limit	$0.30	$0.30
Strike Price Range Upper Limit	$0.49	$0.49
Outstanding Stock Options (in Shares)	395,000	755,000
Weighted Average Remaining Contractual Life	'189 days	'288 days
Weighted Average Outstanding Strike Price	$0.46	$0.45
Vested Stock Options (in Shares)	395,000	755,000
Weighted Average Remianing Vested Life	'189 days	'288 days
Weighted Average Vested Strike Price	$0.46	$0.45
Strike Price Range 0.50 to 0.70 [Member]	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'
Strike Price Range Lower Limit	$0.50	$0.50
Strike Price Range Upper Limit	$0.70	$0.70
Outstanding Stock Options (in Shares)	1,644,000	3,719,000
Weighted Average Remaining Contractual Life	'1 year 43 days	'354 days
Weighted Average Outstanding Strike Price	$0.59	$0.60
Vested Stock Options (in Shares)	1,644,000	3,719,000
Weighted Average Remianing Vested Life	'1 year 43 days	'354 days
Weighted Average Vested Strike Price	$0.59	$0.60
Strike Price Range 0.00 to 0.70 [Member]	'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'
Strike Price Range Lower Limit	$0	$0
Strike Price Range Upper Limit	$0.70	$0.70
Outstanding Stock Options (in Shares)	6,175,000	10,452,500
Weighted Average Remaining Contractual Life	'1 year 262 days	'1 year 248 days
Weighted Average Outstanding Strike Price	$0.30	$0.36
Vested Stock Options (in Shares)	5,329,166	9,059,083
Weighted Average Remianing Vested Life	'1 year 164 days	'1 year 131 days
Weighted Average Vested Strike Price	$0.33	$0.39

Note_14_Employee_Equity_Incent6

Note 14 - Employee Equity Incentive Plans (Details) - Fair Value Assumptions of Share-Based Payments	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Fair Value Assumptions of Share-Based Payments [Abstract]	'	'
Risk-free interest rate	0.70%	0.37%
Expected dividend yield	0.00%	0.00%
Expected volatility	203.40%	186.60%
Expected life of options (in years)	'5 years	'5 years

Note_14_Employee_Equity_Incent7

Note 14 - Employee Equity Incentive Plans (Details) - Weighted Average Grant Date Fair Value Activity (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Weighted Average Grant Date Fair Value Activity [Abstract]	'	'
Stock options granted during the nine month period ended September 30,	$0.17	$0.10
Stock options vested during the nine month period ended September 30,	$0.10	$0.10
Stock options forfeited during the nine month period ended September 30,	$0.28	$0.33

Note_14_Employee_Equity_Incent8

Note 14 - Employee Equity Incentive Plans (Details) - Status of Non-Vested Shares (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Note 14 - Employee Equity Incentive Plans (Details) - Status of Non-Vested Shares [Line Items]	'	'
Weighted average grant date fair value (in Dollars per share)	$0.10	$0.10
Beginning of Period [Member]	'	'
Note 14 - Employee Equity Incentive Plans (Details) - Status of Non-Vested Shares [Line Items]	'	'
Shares underlying stock options	1,393,417	'
Weighted average grant date fair value (in Dollars per share)	$0.10	'
End of Period [Member]	'	'
Note 14 - Employee Equity Incentive Plans (Details) - Status of Non-Vested Shares [Line Items]	'	'
Shares underlying stock options	845,834	'
Weighted average grant date fair value (in Dollars per share)	$0.12	'

Note_15_Income_Taxes_Details

Note 15 - Income Taxes (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Income Tax Disclosure [Abstract]	'
Operating Loss Carryforwards	$49,779,986
Valuation Allowance, Deferred Tax Asset, Change in Amount	$480,839

Note_15_Income_Taxes_Details_R

Note 15 - Income Taxes (Details) - Reconciliation of Income Tax Expense (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Reconciliation of Income Tax Expense [Abstract]	'	'	'	'
Federal statutory rate applied to loss before income taxes	'	'	($1,662,692)	($2,327,610)
Current tax expense	'	'	48,599	54,699
Non deductible expenses	'	'	1,144,767	1,961,459
Change in deferred assets	'	'	37,086	62,632
Change in valuation allowance	'	'	480,839	303,519
Income tax expense	$30,869	$54,699	$48,599	$54,699

Note_15_Income_Taxes_Details_T

Note 15 - Income Taxes (Details) - The Components of Income Tax Expense (Benefit) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Note 15 - Income Taxes (Details) - The Components of Income Tax Expense (Benefit) [Line Items]	'	'	'	'
Current tax expense:	'	'	$48,599	$54,699
Deferred tax expense/(benefit):	'	'	'	'
Deferred tax expense (benefit)	'	'	-480,839	-303,519
Valuation allowance	'	'	480,839	303,519
Total tax expense	30,869	54,699	48,599	54,699
Bad Debt Allowance [Member]	'	'	'	'
Deferred tax expense/(benefit):	'	'	'	'
Deferred tax expense (benefit)	'	'	13,106	-47,701
Operating Loss Carryforward [Member]	'	'	'	'
Deferred tax expense/(benefit):	'	'	'	'
Deferred tax expense (benefit)	'	'	-531,031	-318,450
Patent Litigation Settlement [Member]	'	'	'	'
Deferred tax expense/(benefit):	'	'	'	'
Deferred tax expense (benefit)	'	'	$37,086	$62,632

Note_15_Income_Taxes_Details_D

Note 15 - Income Taxes (Details) - Deferred Taxes Assets and Liabilities (USD $)	Sep. 30, 2013	Sep. 30, 2012
Deferred Taxes Assets and Liabilities [Abstract]	'	'
Amortization of intangibles	$283,698	$283,698
Bad debt allowance	17,608	100,330
Patent litigation liability accrual	349,596	401,020
Operating loss carryforwards	17,887,001	17,238,505
Gross deferred tax assets	18,537,904	18,023,553
Valuation allowance	-18,537,904	-18,023,553
Net deferred tax liability/(asset)	$0	$0

Note_16_Subsequent_Events_Deta

Note 16 - Subsequent Events (Details) (Subsequent Event [Member])	Nov. 11, 2013	Nov. 11, 2013	Nov. 11, 2013	Nov. 11, 2013	Oct. 02, 2013
	Promasys B.V. [Member]	Share Exchange Agreement [Member]	Share Exchange Agreement [Member]	Non US Persons/ Non US Entities [Member]	USD ($)
		USD ($)	EUR (€)
Note 16 - Subsequent Events (Details) [Line Items]	'	'	'	'	'
Business Acquisition, Percentage of Voting Interests Acquired	100.00%	'	'	'	'
Business Acquisition, Number Of Shareholders in Exchange Agreement	4	'	'	3	'
Business Combination, Consideration Transferred (in Euro)	'	$593,000	€ 435,998	'	'
Business Combination, Consideration Transferred (in Dollars)	'	593,000	435,998	'	'
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares)	'	2,270,000	2,270,000	'	'
Business Acquisition Equity Interest Issued or Issuable Value Per Share (in Dollars per share)	'	$0.25	'	'	'
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned (in Dollars)	'	567,500	'	'	'
Proceeds from Issuance of Debt (in Dollars)	'	'	'	'	$750,000